Abstract
Rapid incorporation of microarray analysis/aCGH for studies of children with developmental disabilities and its endorsement as a first-tier test for these children [1] has yielded a vast number of subtle chromosome changes that were unseen by routine karyotyping.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Miller DT et al (2010) Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital defects. Am J Hum Genet 86:749–764
South ST et al (2013) ACMG Standards and guidelines for constitutional cytogenomic microarray analysis, including postnatal and prenatal applications: revision 2013. Genet Med 15:901–909
Online Mendelian Inheritance in Man. www.omim.org; PubMed. http://www.ncbi.nlm.nih.gov/pubmed
Cohen MMJr (1977) On the nature of syndrome delineation. Acta Genet Med Gemellol 26:103–119
Girirajan S et al (2012) Phenotypic heterogeneity of genomic disorders and rare copy-number variants. N Eng J Med 367:1321–1331
Brunner HG (2012) The variability of human disease. New Engl J Med 367:1350–1352
Wilson GN (1992) Genomics of human dysmorphogenesis. Am J Med Genet 42:187–196
Chromosome lengths taken from www.ncbi.nlm.nih.gov/. Accessed June 2016
Lupski JR (1998) Genomic disorders: structural features of the genome can lead to DNA rearrangements and human disease traits. Trends Genet 14:417–422
Wyandt HE, Tonk VS (2011) Human chromosome variation: heteromorphism and polymorphism. Springer, Dordrecht
Gajecka M, Mackay KL, Shaffer LG (2007) Monosomy 1p36 deletion syndrome. Am J Med Genet C Semin Med Genet 145C:346–356
Lee MS et al (2015) Overlap of autism spectrum disorder and glucose transporter 1 deficiency syndrome associated with a heterozygous deletion at the 1p34.2 region. J Neurol Sc 356:212–214
Tokita MJ et al (2015) Five children with deletions of 1p34.3 encompassing AGO1 and AGO3. Eur J Hum Genet 23:761–765
Takenouchi T et al (2014) 1p34.3 deletion involving GRIK3: further clinical implication of GRIK family glutamate receptors in the pathogenesis of developmental delay. Am J Med Genet A 164A:456–460
Koehler U et al (2010) A novel 1p31.3p32.2 deletion involving the NFIA gene detected by array CGH in a patient with macrocephaly and hypoplasia of the corpus callosum. Europ J. Pediat 169:463–468
Kehrer M et al (2015) Interstitial 1p32.1p32.3 deletion in a patient with multiple congenital defects. Am J Med Genet A 167A:2406–2410
Vauthier V et al (2012) Homozygous deletion of an 80 kb region comprising part of DNAJC6 and LEPR genes on chromosome 1p31.3 is associated with early onset obesity, mental retardation and epilepsy. Mol Genet Metab 106:345–350
Tassano E et al (2015) Clinical and molecular mytogenetic characterization of a de novo interstitial 1p31.1p31.3 deletion in a boy with moderate intellectual disability and severe language impairment. Cytogenet Genome Res 146:39–43
Sajan SA et al (2013) Both rare and de novo copy number variants are prevalent in agenesis of the corpus callosum but not in cerebellar hypoplasia or polymicrogyria. PLoS Genet 9(10):e1003823. doi:10.1371/journal.pgen.1003823
Radhakrishna U et al (2012) Genome-wide linkage and copy number variation analysis reveals 710 kb duplication on chromosome 1p31.3 responsible for autosomal dominant omphalocele. J Med Genet 49:270–276
Maegawa GH et al (2008) Interstitial deletion of 1p22.2p31.1 and medium-chain acyl-CoA dehydrogenase deficiency in a patient with global developmental delay. Am J Med Genet A 146A:1581–1586
Callier P (2008) Array-CGH in a series of 30 patients with mental retardation, dysmorphic features, and congenital malformations detected an interstitial 1p22.2-p31.1 deletion in a patient with features overlapping the Goldenhar syndrome. Am J Med Genet A 146A(16):2109–2115
Willemsen MH et al (2011) Chromosome 1p21.3 microdeletions comprising DPYD and MIR137 are associated with intellectual disability. J Med Genet 48:810–818
Carter MT et al (2011) Hemizygous deletions on chromosome 1p21.3 involving the DPYD gene in individuals with autism spectrum disorder. Clin Genet 80:435–443
Mefford H et al (2008) Recurrent rearrangements of chromosome 1q21.1 and variable pediatric phenotypes. New Eng J Med 359:1685–1699
Brunetti-Pierri N et al (2008) Recurrent reciprocal 1q21.1 deletions and duplications associated with microcephaly or macrocephaly and developmental and behavioral abnormalities. Nat Genet 40:1466–1471
Papoulidis I et al (2013) Prenatal detection of TAR syndrome in a fetus with compound inheritance of an RBM8A SNP and a 334-kb deletion: a case report. Mol Med Rep 9:163–165
Quinonez SC et al (2012) Maternal intrachromosomal insertional translocation leads to recurrent 1q21.3q23.3 deletion in two siblings. Am J Med Genet A 158A:2591–2601
Ashraf T et al (2015) Two further patients with the 1q24 deletion syndrome expand the phenotype: a possible role for the miR199–214 cluster in the skeletal features of the condition. doi:10.1002/ajmg.a.37336 [Epub ahead of print]
Burkardt DD et al (2011) Distinctive phenotype in 9 patients with deletion of chromosome 1q24-q25. Am J Med Genet A 155A:1336–1351
Harrison SM, Seideman C, Baker LA (2014) DNA copy number variations in patients with persistent cloaca. J Urol 191(5 Suppl):1543–1546
Tan EC, Lim EC, Lee ST (2013) De novo 2.3 Mb microdeletion of 1q32.2 involving the Van der Woude Syndrome locus. Mol Cytogenet 6:31
Salahshourifar I et al (2011) De novo interstitial deletion of 1q32.2-q32.3 including the entire IRF6 gene in a patient with oral cleft and other dysmorphic features. Cytogenet Genome Res 134:83–87
Shaffer LG et al (2007) The discovery of microdeletion syndromes in the post-genomic era: review of the methodology and characterization of a new 1q41q42 microdeletion syndrome. Genet Med 9:607–616
Petersen AK (2013) Deletion 1q43 encompassing only CHRM3 in a patient with autistic disorder. Eur J Med Genet 56:118–122
Perrone MD et al (2012) De novo 911 Kb interstitial deletion on chromosome 1q43 in a boy with mental retardation and short stature. Eur J Med Genet 55:117–119
Perlman SJ et al (2013) Haploinsufficiency of ZNF238 is associated with corpus callosum abnormalities in 1q44 deletions. Am J Med Genet A 161A:711–716
Selmer KK et al (2012) A de novo 163 kb interstitial 1q44 microdeletion in a boy with thin corpus callosum, psychomotor delay and Epilepsy. Eur J Med Genet 55:715–718
Thierry G et al (2012) Molecular characterization of 1q44 microdeletion in 11 patients reveals three candidate for intellectual disability and Epilepsy. Am J Med Genet A 158A:1633–1640
Caliebe A et al (2010) Four patients with speech delay, Epilepsy and variable corpus callosum thickness sharing a 0.440 Mb deletion in region 1q44 containing the HNRPU gene. Eur J Med Genet 53:179–185
Poot M et al (2012) Kooy F, Hochstenbach R. Dandy-Walker complex in a boy with a 5 Mb deletion of region 1q44 due to a paternal t(1;20)(q44;q13.33). Am J Med Genet A 143A:1038–1044
De Rocker N et al (2015) Refinement of the critical 2p25.3 deletion region: the role of MYT1L in intellectual disability and obesity. Genet Med 17:460–466
Sperry ED et al (2016) Duplication 2p25 in a child with clinical features of CHARGE syndrome. Am J Med Genet A 170A:1148–1154
Lee Y et al (2012) Microduplications disrupting the MYT1L gene (2p25.3) are associated with schizophrenia. Psychiatr Genet 22:206–209
van Bokhoven H et al (2005) MYCN haploinsufficiency is associated with reduced brain size and intestinal atresias in Feingold syndrome. Nat Genet 37:465–467
Hufnagel RB et al (2016) A new frontonasal dysplasia syndrome associated with deletion of the SIX2 gene. Am J Med Genet A 70A:487–491
Bartholdi D et al (2013) Further delineation of genotype-phenotype correlation in homozygous 2p21 deletion syndromes: first description of patients without cystinuria. Am J Med Genet A 161A:1853–1859
Schell U et al (1996) Molecular characterization of breakpoints in patients with holoprosencephaly and definition of the HPE2 critical region 2p21. Hum Molec Genet 5:223–229
Duong LT et al (2015) Two rare deletions upstream of the NRXN1 gene (2p16.3) affecting the non-coding mRNA AK127244 segregate with diverse psychopathological phenotypes in a family. Eur J Med Genet 58:650–653
Curran S et al (2013) NRXN1 deletions identified by array comparative genome hybridisation in a clinical case series—further understanding of the relevance of NRXN1 to neurodevelopmental disorders. J Mol Psychiatry. doi:10.1186/2049-9256-1-4
Balci TB et al (2015) Brain malformations in a patient with deletion 2p16.1: a refinement of the phenotype to BCL11A. Eur J Med Genet 58:351–354
Felix TM et al (2010) Further characterization of microdeletion syndrome involving 2p15-p16.1. Am J Med Genet 152A:2604–2608
Mimouni-Bloch A et al (2015) A de-novo interstitial microduplication involving 2p16.1-p15 and mirroring 2p16.1-p15 microdeletion syndrome: Clinical and molecular analysis. Eur J Paediatr Neurol 19:711–715
Stevens SJ et al (2014) A recurrent deletion syndrome at chromosome bands 2p11.2-2p12 flanked by segmental duplications at the breakpoints and including REEP1. Eur J Hum Genet 23:543–546
Silipigni R et al (2016) Rare interstitial deletion of chromosome 2p11.2p12. Report of a new patient with developmental delay and unusual clinical features. Eur J Med Genet 59:39–42
Steichen-Gersdorf E et al (2008) Triangular tibia with fibular aplasia associated with a microdeletion on 2q11.2 encompassing LAF4. Clin Genet 74:560–565
Riley KN et al (2015) Recurrent deletions and duplications of chromosome 2q11.2 and 2q13 are associated with variable outcomes. Am J Med Genet A 167A:2664–2673
Hladilkova E et al (2015) A recurrent deletion on chromosome 2q13 is associated with developmental delay and mild facial dysmorphisms. Mol Cytogenet. doi:10.1186/s13039-015-0157-0
Russell MW et al (2014) Functional analysis of candidate genes in 2q13 deletion syndrome implicates FBLN7 and TMEM87B deficiency in congenital heart defects and FBLN7 in craniofacial malformations. Hum Mol Genet 23:4272–4284
Shanske AL et al (2004) Detection of an interstitial deletion of 2q21-22 by high resolution comparative genomic hybridization in a child with multiple congenital defects and an apparent balanced translocation. Am J Med Genet 131A:29–35
Ishihara N et al. Clinical and molecular analysis of Mowat-Wilson syndrome associated with ZFHX1B mutations and deletions at 2q22-q24.1. (Letter) J Med Genet 41:387–393
Silengo M, Ferrero GB, Wakamatsu N (2004) Pachygyria and cerebellar hypoplasia in a patient with a 2q22-q23 deletion that includes the ZFHX1B gene. (Letter) Am J Med Genet 127A:109 only
Bravo-Oro A et al (2015) A novel interstitial deletion of 2q22.3 q23.3 in a patient with dysmorphic features, epilepsy, aganglionosis, pure red cell aplasia, and skeletal malformations. Am J Med Genet A 167A:1865–1871
van Bon BWM et al (2010) The 2q23.1 microdeletion syndrome: clinical and behavioural phenotype. Europ. J. Hum Genet 18:163–170
Williams SR et al (2010) Haploinsufficiency of MBD5 associated with a syndrome involving microcephaly, intellectual disabilities, severe speech impairment, and Epilepsy. Europ J Hum Genet 18:436–441
Talkowski ME et al (2011) Assessment of 2q23.1 microdeletion syndrome implicates MBD5 as a single causal locus of intellectual disability, epilepsy, and autism spectrum disorder. Am J Hum Genet 89:551–563
Chung BHY et al (2012) Severe intellectual disability and autistic features associated with microduplication 2q23.1. Europ J Hum Genet 20:398–403
Newbury DF et al, International Molecular Genetic Study of Autism Consortium (2009) Mapping of partially overlapping de novo deletions across an autism susceptibility region (AUTS5) in two unrelated individuals affected by developmental delays with communication impairment. Am J Med Genet 149A:588–597
Suls A et al (2010) Four generations of epilepsy caused by an inherited microdeletion of the SCN1A gene. Neurology 75:72–76
Goodman FR (2002) A 117-kb microdeletion removing HOXD9-HOXD13 and EVX2 causes synpolydactyly. Am J Hum Genet 70:547–555
Puvabanditsin S et al (2015) 2q31.1 microdeletion syndrome: case report and literature review. Clin Case Rep 3:357–360
Cho T-J et al (2010) A dominant mesomelic dysplasia associated with a 1.0-Mb microduplication of HOXD gene cluster at 2q31.1. J Med Genet 47:638–639
Ghoumid J et al. Duplication at chromosome 2q31.1-q31.2 in a family presenting syndactyly and nystagmus. Europ J Hum Genet 19:1198–1201
Glass IA et al (1989) Interstitial deletion of the long arm of chromosome 2 with normal levels of isocitrate dehydrogenase. J Med Genet 26:127–140
Rifai L et al (2010) Ectodermal dysplasia-like syndrome with mental retardation due to contiguous gene deletion: further clinical and molecular delineation of del(2q32) syndrome. Am J Med Genet 152A:111–117
Gregoric Kumperscak H, Krgovic D, Vokac NK (2016) Specific behavioural phenotype and secondary cognitive decline as a result of an 8.6 Mb deletion of 2q32.2q33.1. J Int Med Res 44:395–402
Papoulidis I et al (2015) Deletion of 4.4 Mb at 2q33.2q33.3 may cause growth deficiency in a patient with mental retardation, facial dysmorphic features and speech delay. Cytogenet Genome Res 145:19–24
Klopocki E et al (2011) Copy-number variations involving the IHH locus are associated with syndactyly and craniosynostosis. Am J Hum Genet 88:70–75
Jean-Marcais N et al (2015) The first familial case of inherited 2q37.3 interstitial deletion with isolated skeletal abnormalities including brachydactyly type E and short stature. Am J Med Genet 167A:185–189
Ogura K et al (2014) Neuropsychological profiles of patients with 2q37.3 deletion associated with developmental dyspraxia. Am J Med Genet 165B:684–690
Williams SR et al (2010) Array comparative genomic hybridisation of 52 subjects with a Smith-Magenis-like phenotype: identification of dosage sensitive loci also associated with schizophrenia, autism, and developmental delay. J Med Genet 47:223–229
Kuechler A et al (2015) Loss-of-function variants of SETD5 cause intellectual disability and the core phenotype of microdeletion 3p25.3 syndrome. Europ J Hum Genet 23:753–760
Fernandez T et al (2008) Disruption of contactin 4 (CNTN4) results in developmental delay and other features of 3p deletion syndrome. Am J Hum Genet 74:1286–1293
Roohi J et al (2009) Disruption of contactin 4 in three subjects with autism spectrum disorder. J Med Genet 46:176–182
Palumbo O et al (2015) De novo microduplication of CHL1 in a patient with non-syndromic developmental phenotypes. Mol Cytogenet 8:66. doi:10.1186/s13039-015-0170-3
Luo C et al (2012) Micoduplication of 3p25.2 encompassing RAF1 associated with congenital heart disease suggestive of Noonan syndrome. Am J Med Genet A 158(A):1918–1923
de la Hoz AB et al (2015) De novo interstitial microdeletion in a patient with intellectual disability and autistic features with language impairment: a comparison with similar cases. Case Rep Genet 876348. doi:10.1155/2015/876348
Molin A-M et al (2012) A novel microdeletion syndrome at 3q13.31 characterised by developmental delay, postnatal overgrowth, hypoplastic male genitals, and characteristic facial features. J Med Genet 49:104–109
Shuvarikov A (2013) Recurrent HERV-H-mediated 3q13.2-q13.31 deletions cause a syndrome of hypotonia and motor, language, and cognitive delays. Hum Mutat 34:1415–1423
Beysen D et al (2005) Deletions involving long-range conserved nongenic sequences upstream and downstream of FOXL2 as a novel disease-causing mechanism in blepharophimosis syndrome. Am J Hum Genet 77:205–218
Dean SJ et al (2014) Acquired microcephaly in blepharophimosis-ptosis-epicanthus inversus syndrome because of an interstitial 3q22.3q23 deletion. Pediatr Neurol 50:636–639
Khan AO et al (2014) Limited ocular motility in a child with 3q23 microdeletion (“blepharophimosis syndrome plus”). J Pediatr Ophthalmol Strabismus. Online:e51–4. doi:10.3928/01913913-20140709-04
Chang YT et al (2014) Case report of Chromosome 3q25 deletion syndrome or mucopolysaccharidosis IIIB. Biomedicine (Taipei) 4:7
McGoey R, Varma A, Lacassie Y (2010) Siblings with phenotypic overlap with Toriello-Carey syndrome and complex cytogenetic imbalances including 3q29 microduplication and 6p25 microdeletion: review of the literature and additional evidence for genetic heterogeneity. Am J Med Genet 152A:3068–3073
Li F et al (2009) 3q29 interstitial microdeletion syndrome: an inherited case associated with cardiac defect and normal cognition. Europ J Med Genet 52:349–353
Willatt L et al (2005) 3q29 microdeletion syndrome: clinical and molecular characterization of a new syndrome. Am J Hum Genet 77:154–160
Lisi EC et al (2008) 3q29 interstitial microduplication: a new syndrome in a three-generation family. Am J Med Genet 146A:601–609
Maas NMC et al (2008) Genotype-phenotype correlation in 21 patients with Wolf-Hirschhorn syndrome using high resolution array comparative genome hybridisation (CGH). J Med Genet 45:71–80
Van Buggenhout G (2004) Mild Wolf-Hirschhorn syndrome: micro-array CGH analysis of atypical 4p16.3 deletions enables refinement of the genotype-phenotype map. J Med Genet 41:691–698
Partington MW et al (1997) Translocations involving 4p16.3 in three families: deletion causing the Pitt-Rogers-Danks syndrome and duplication resulting in a new overgrowth syndrome. J Med Genet 34:719–728
Palumbo O et al (2015) Report of a patient and further clinical and molecular characterization of interstitial 4p16.3 microduplication. Mol Cytogenet 8:15. doi:10.1186/s13039-015-0119-6
Chen CP et al (2013) Prenatal diagnosis and molecular cytogenetic characterization of a de novo proximal interstitial deletion of chromosome 4p (4p15.2→p14). Gene 529:351–356
Kaindl AM et al (2005) Homozygous microdeletion of chromosome 4q11-q12 causes severe limb-girdle muscular dystrophy type 2E with joint hyperlaxity and contractures. Hum Mutat 26:279–280
Hemati P, du Souich C, Boerkoel CF (2015) 4q12-4q21.21 deletion genotype-phenotype correlation and the absence of piebaldism in presence of KIT haploinsufficiency. Am J Med Genet A 167A:231–237
Zhang Y et al (2015) [Analysis of genomic copy number variations in two sisters with primary amenorrhea and hyperandrogenism] [Article in Chinese] 32:814–818
Bonnet C et al (2010) Microdeletion at chromosome 4q21 defines a new emerging syndrome with marked growth restriction, mental retardation and absent or severely delayed speech. J Med Genet 47:377–384
Friedman JM et al (2006) Oligonucleotide microarray analysis of genomic imbalance in children with mental retardation. Am J Hum Genet 79:500–513
Komlósi K et al (2015) Phenotypic variability in a Hungarian patient with the 4q21 microdeletionsyndrome. Mol Cytogenet 8:16. doi:10.1186/s13039-015-0118-7
Sakazume S et al (2015) Additional patients with 4q deletion: severe growth delay and polycystic kidney disease associated with 4q21q22 loss. Pediatr Int 57:880–883
Flomen RH (1998) Construction and analysis of a sequence-ready map in 4q25: Rieger syndrome can be caused by haploinsufficiency of RIEG, but also by chromosome breaks approximately 90 kb upstream of this gene. Genomics 47:409–413
Lines MA et al (2004) Characterization and prevalence of PITX2 microdeletions and mutations in Axenfeld-Rieger malformations. Invest Ophthal Vis Sci 45:828–833
Ronzoni L (2015) Molecular cytogenetic characterization of a 2q35-q37 duplication and a 4q35.1-q35.2 deletion in two cousins: a genotype-phenotype analysis. Am J Med Genet A 167:1551–1559
Fu F et al (2016) Prenatal diagnosis of fetal multicystic dysplastic kidney via high-resolution whole-genome array. Nephrol Dial Transplant. doi:10.1093/ndt/gfv465
Cerruti Mainardi P et al (2001) Clinical and molecular characterisation of 80 patients with 5p deletion: genotype-phenotype correlation. J Med Genet 38:151–158
Zhang X et al (2005) High-resolution mapping of genotype-phenotype relationships in cri duchat syndrome using array comparative genomic hybridization. Am J Hum Genet 76:312–326
Izzo G (2013) A microduplication of 5p15.33 reveals CLPTM1L as a candidate gene for cleft lip and palate. Eur J Med Genet 56:222–225
Iourov IY (2015) 5p13.3p13.2 duplication associated with developmental delay, congenital malformations and chromosome instability manifested as low-level aneuploidy. Springerplus 4:616. doi:10.1186/s40064-015-1399-3
Yan J et al (2009) Genomic duplication resulting in increased copy number of genes encoding the sister chromatid cohesion complex conveys clinical consequences distinct from Cornelia de Lange. (Letter). J Med Genet 46:626–634
Sobreira N et al (2009) Interstitial deletion 5q14.3-q21 associated with iris coloboma, hearing loss, dental anomaly, moderate intellectual disability, and attention deficit and hyperactivity disorder. Am J Med Genet 149A:2581–2583
Ilari R, Agosta G, Bacino C (2016) 5q14.3 deletion neurocutaneous syndrome: contiguous gene syndrome caused by simultaneous deletion of RASA1 and MEF2C: a progressive disease. Am J Med Genet A 170:688–693
Cardoso C et al (2009) Periventricular heterotopia, mental retardation, and epilepsy associated with 5q14.3-q15 deletion. Neurology 72:784–792
Tonk V et al (2011) Interstitial deletion 5q14.3q21.3 with MEF2C haploinsufficiency and mild phenotype: when more is less. Am J Med Genet 155A:1411–1437
Alvarado DM et al (2011) Pitx1 haploinsufficiency causes clubfoot in humans and a clubfoot-like phenotype in mice. Hum Molec Genet 20:3943–3952
Brown N et al (2013) 5q31.3 Microdeletion syndrome: clinical and molecular characterization of two further cases. Am J Med Genet 161A:2604–2608
Lalani SR et al (2014) Mutations in PURA cause profound neonatal hypotonia, epilepsy, and encephalopathy in 5q31.3 microdeletion syndrome. Am J Hum Genet 95:579–583
Hirai N, Matsune K, Ohashi H (2011) Craniofacial and oral features of Sotos syndrome: differences in patients with submicroscopic deletion and mutation of NSD1 gene. Am J Med Genet 155A:2933–2939
Kurotaki N et al (2003) Fifty microdeletions among 112 cases of Sotos syndrome: low copy repeats possibly mediate the common deletion. Hum Mutat 22:378–387
Chen CP et al (2014) Prenatal diagnosis and molecular cytogenetic characterization of a 1.07-Mb microdeletion at 5q35.2-q35.3 associated with NSD1 haploinsufficiency and Sotos syndrome. Taiwan J Obstet Gynecol 53:583–587
Dikow N et al (2013) The phenotypic spectrum of duplication 5q35.2-q35.3 encompassing NSD1: is it really a reversed Sotos syndrome? Am J Med Genet A 161A:2158–2166
Rosenfeld JA et al (2013) Further evidence of contrasting phenotypes caused by reciprocal deletions and duplications: duplication of NSD1 causes growth retardation and microcephaly. Mol Syndromol 3(6):247–254
Linhares ND et al (2015) Subtelomeric 6p25 deletion/duplication: report of a patient with new clinical findings and genotype-phenotype correlations. Eur J Med Genet 58:310–318
Lin RJ et al (2015) Terminal deletion of 6p results in a recognizable phenotype. Am J Med Genet 136A:162–168
Mirza G et al (2004) Refined genotype-phenotype correlations in cases of chromosome 6p deletion syndromes. Europ. J. Hum Genet 12:718–728
Yoshimura-Furuhata M et al (2015) Renal complications in 6p duplication syndrome: microarray-based investigation of the candidate gene(s) for the development of congenital defects of the kidney and urinary tract (CAKUT) and focal segmental glomerular sclerosis (FSGS). Am J Med Genet A 167A:592–601
Flottmann R et al (2015) Microdeletions on 6p22.3 are associated with mesomelic dysplasia Savarirayan type. J Med Genet 52:476–483
Ladinsky HT et al (2014) Hypereosinophilic syndrome and hemimelia in a patient with chromosome 6p22.3 deletion. (Letter) Pediat Allergy Immun 25:500–503
Gelb BD et al (1995) Genetic mapping of the cleidocranial dysplasia (CCD) locus on chromosome band 6p21 to include a microdeletion. Am J Med Genet 58:200–205
Van Esch H et al (2010) Developmental delay and connective tissue disorder in four patients sharing a common microdeletion at 6q13-14. J Med Genet 47:717–720
Wang J-C et al (2009) Molecular breakpoint mapping of 6q11-q14 interstitial deletions in seven patients. Am J Med Genet 149A:372–379
Lowry RB et al (2013) Interstitial deletions at 6q14.1q15 associated with developmental delay and a marfanoid phenotype. Mol Syndromol 4:280–284
Landais E et al (2015) A pure familial 6q15q21 split duplication associated with obesity and transmitted with partial reduction. Am J Med Genet A 167:1275–1284
El Khattabi L et al (2015) Incomplete penetrance and phenotypic variability of 6q16 deletions including SIM1. Eur J Hum Genet 23:1010–1018
Hudson C et al (2014) Confirmation of 6q21-6q22.1 deletion in acro-cardio-facial syndrome and further delineation of this contiguous gene deletion syndrome. Am J Med Genet A 164A:2109–2113
Szafranski P et al (2015) 6q22.1 microdeletion and susceptibility to pediatric epilepsy. Eur J Hum Genet 23:173–179
Bisgaard A-M et al (2006) Additional chromosomal abnormalities in patients with a previously detected abnormal karyotype, mental retardation, and dysmorphic features. Am J Med Genet 140A:2180–2187
Caselli R et al (2007) A 2.6 Mb deletion of 6q24.3-25.1 in a patient with growth failure, cardiac septal defect, thin upper lip and asymmetric dysmorphic ears.Europ. J Med Genet 50:315–321
Nagamani SCS et al (2009) Interstitial deletion of 6q25.2-q25.3: a novelmicrodeletion syndrome associated with microcephaly, developmental delay, dysmorphic features and hearing loss. Europ J Hum Genet 17:573–581
Ronzoni L et al (2016) Interstitial 6q25 microdeletion syndrome: ARID1B is the key gene. Am J Med Genet A 170A:1257–1261
Weiss K et al (2015) TAB2 microdeletion and congenital heart defects including unusual valve dysplasia and tetralogy of Fallot. Am J Med Genet 167A:2702–2706
Conti V et al (2013) Periventricular heterotopia in 6q terminal deletion syndrome: role of the C6orf70 gene. Brain 136:3378–3394
Zhou L et al (2014) Delineation variable genotype/phenotype correlations of 6q27 terminal deletion derived from dic(6;18)(q27;p10). Mol Cytogenet 7:78. doi:10.1186/s13039-014-0078-3
Burnside MN et al (2015) Complex brain malformations associated with chromosome 6q27 gain that includes THBS2, which encodes thrombospondin 2, an astrocyte-derived protein of the extracellular matrix. Pediatr Dev Pathol 18:59–65
Girisha KM et al (2014) A syndrome of facial dysmorphism, cubital pterygium, short distal phalanges, swan neck deformity of fingers, and scoliosis. Am J Med Genet A 164A:1035–1040
Caselli R et al (2015) 7p22.1 microduplication syndrome: clinical and molecular characterization of an adult case and review of the literature. Eur J Med Genet 58:578–583
Goitia V, Oquendo M, Stratton R (2015) Case of 7p22.1 microduplication detected by whole genome microarray (REVEAL) in workup of child diagnosed with autism. Case Rep Genet 212436. doi:10.1155/2015/212436
Kroisel PM, Petek E, Wagner K (2001) Phenotype of five patients with Greig syndrome and microdeletion of 7p13. Am J Med Genet 102:243–249
Motegi T et al (1985) A craniosynostosis in a boy with a del(7)(p15.3p21.3): assignment by deletion mapping of the critical segment for craniosynostosis to the mid-portion of 7p21. Hum Genet 71:160–162
Zackai EH, Stolle CA (1998) A new twist: some patients with Saethre-Chotzen syndrome have a microdeletion syndrome (Editorial). Am J Hum Genet 63:1277–1281
Cho E et al (2013) Saethre-Chotzen syndrome with an atypical phenotype: identification of TWIST microdeletion by array CGH. Childs Nerv Syst 29:2101–2104
Nagamani SCS et al (2013) Detection of copy-number variation in AUTS2 gene by targeted exonic array CGH in patients with developmental delay and autistic spectrum disorders. Europ J Hum Genet 21:343–346
Wu Y-Q et al (1998) Delineation of the common critical region in Williams syndrome and clinical correlation of growth, heart defects, ethnicity, and parental origin. Am J Med Genet 78:82–89
Strong E et al (2015) Symmetrical dose-dependent DNA-methylation profiles in children with deletion or duplication of 7q11.23. Am J Hum Genet 97:216–227
Morris CA et al (2015) 7q11.23 duplication syndrome: physical characteristics and natural history. Am J Med Genet 167A:2916–2935
Marshall CR et al (2008) Infantile spasms is associated with deletion of the MAG12 gene on chromosome 7q11.23-q21.11. Am J Hum Genet 83:106–111
Röthlisberger B et al (2010) Deletion of 7q11.21-q11.23 and infantile spasms without deletion of MAGI2. Am J Med Genet A 152A:434–437
Peterson JF et al (2014) Seizure Disorder in a Patient with a 5.09 Mb 7q11.23-q21.11 Microdeletion Including the MAGI2 Gene. J Assoc Genet Technol 40:16–21
Haberlandt E et al (2001) Split hand/split foot malformation associated with sensorineural deafness, inner and middle ear malformation, hypodontia, congenital vertical talus, and deletion of eight microsatellite markers in 7q21.1-q21.3. J Med Genet 38:405–409
Velinov M (2012) A 0.7 Mb de novo duplication at 7q21.3 including the genes DLX5 and DLX6 in a patient with split-hand/split-foot malformation. Am J Med Genet 158A:3201–3206
Yu C-E et al (2002) Presence of large deletions in kindreds with autism. Am J Hum Genet 71:100–115
Fisher SE et al (1998) Localisation of a gene implicated in a severe speech and language disorder. Nat Genet 18:168–170
Rice GM et al (2012) Phenotype of FOXP2 haploinsufficiency in a mother and son. Am J Med Genet 158A:174–181
Tyson C et al (2004) Elucidation of a cryptic interstitial 7q31.3 deletion in a patient with a language disorder and mild mental retardation by array-CGH. Am J Med Genet 129A:254–260
Dilzell K et al (2015) Deletion of 7q33-q35 in a patient with intellectual disability and dysmorphic features: Further characterization of 7q interstitial deletion syndrome. Case Rep Genet 2015:131852. doi:10.1155/2015/131852
Rush ET et al (2013) Report of a patient with developmental delay, hearing loss, growth retardation, and cleft lip and palate and adeletion of 7q34-36.1: review of distal 7q deletions. Am J Med Genet A 161A:1726–1732
Lurie IW et al (1990) Chromosome 7 abnormalities in parents of children with holoprosencephaly and hydronephrosis. Am J Med Genet 35:286–288
Duburg C et al (2004) Molecular screening of SHH, ZIC2, SIX3, and TGIF genes in patients with features of holoprosencephaly spectrum: mutation review and genotype-phenotype correlations. Hum Mutat 24:43–51
Ayub S et al (2016) Three new cases of terminal deletion of the long arm of chromosome 7 and literature review to correlate genotype and phenotype manifestations. Am J Med Genet A 170A:896–907
Molck MC et al (2015) 8p23.1 interstitial deletion in a patient with congenital cardiopathy, neurobehavioral disorders, and minor signs suggesting 22q11.2 deletion syndrome. J Dev Behav Pediatr 36:544–548
Faivre L et al (1998) Prenatal diagnosis of an 8p23.1 deletion in a fetus with diaphragmatic hernia and review of the literature. Prenat Diag 18:1055–1060
Shimokawa O et al (2005) Molecular characterization of del(8)(p23.1p23.1) in a case of congenital diaphragmatic hernia. Am J Med Genet 136A:49–51
Slavotinek A et al (2005) Fryns syndrome phenotype caused by chromosome microdeletions at 15q26.2 and 8p23.1. (Letter). J Med Genet 42:730–736
Barber JC et al (2015) Inside the 8p23.1 duplication syndrome; eight microduplications of likely or uncertain clinical significance. Am J Med Genet A 167A:2052–2064
Weber A et al (2014) 8p23.1 duplication syndrome: narrowing of critical interval to 1.80 Mbp. Mol Cytogenet 9;7(1):94. doi:10.1186/s13039-014-0094-3
Isidor B et al (2010) Mesomelia-synostoses syndrome results from deletion of SULF1 and SLCO5A1 genes at 8q13. Am J Hum Genet 87:95–100
Palomares M et al (2011) Characterization of a 8q21.11microdeletion syndrome associated with intellectual disability and a recognizable phenotype. Am J Hum Genet 89:295–301
Jain S, Yang P, Farrell SA (2010) A case of 8q22.1 microdeletion without the Nablus mask-like facial syndrome phenotype. Europ J Med Genet 53:108–110
Banka S et al (2015) Leri’s pleonosteosis, a congenital rheumatic disease, results from microduplication at 8q22.1 encompassing GDF6 and SDC2 and provides insight into systemic sclerosis pathogenesis. Ann Rheum Dis 74:1249–1256
Leri A (1921) Une maladie congenitale et hereditaire de l’ossification: la pleonosteose familiale. Bull Mem Soc Med Hop Paris 45:1228–1230
Hou J et al (1995) A 4-megabase YAC contig that spans the Langer-Giedion syndrome region on human chromosome 8q24.1: use in refining the location of the trichorhinophalangeal syndrome and multiple exostoses genes (TRPS1 and EXT1). Genomics 29:87–97
Li Q et al (2015) Annular pancreas in trichorhinophalangeal syndrome type II with 8q23.3-q24.12 interstitial deletion. Mol Cytogenet 8:95. doi:10.1186/s13039-015-0201-0
Wells C et al (2016) First fetal case of the 8q24.3 contiguous genes syndrome. Am J Med Genet A 170:239–242
Tassano E et al (2015) Interstitial 9p24.3 deletion involving only DOCK8 and KANK1 genes in two patients with non-overlapping phenotypic traits. Eur J Med Genet 59:20–25
Genesio R et al (2015) Constitutional chromothripsis involving the critical region of 9q21.13 microdeletion syndrome. Mol Cytogenet 8:96. doi:10.1186/s13039-015-0199-3
Hancarova M et al (2015) Deletions of 9q21.3 including NTRK2 are associated with severe phenotype. Am J Med Genet A 167A:264–267
Pua HH et al (2014) Novel interstitial 2.6 Mb deletion on 9q21 associated with multiple congenital defects. Am J Med Genet A 164A:237–242
Reichert SC et al (2015) Diagnosis of 9q22.3 microdeletion syndrome in utero following identification of craniosynostosis, overgrowth, and skeletal defects. Am J Med Genet A 167A:862–865
Garavelli L et al (2013) Multiple tumor types including leiomyoma and Wilms tumor in a patient with Gorlin syndrome due to 9q22.3 microdeletion encompassing the PTCH1 and FANC-C loci. Am J Med Genet A 161A:2894–2901
Cao R et al (2015) Patients carrying 9q31.1-q32 deletion share common features with Cornelia de Lange Syndrome. Cell Physiol Biochem 35:270–280
Mucciolo M et al (2014) 9q31.1q31.3 deletion in two patients with similar clinical features: a newly recognized microdeletion syndrome? Am J Med Genet A 164A:685–690
Harrison SM et al (2013) Screening and familial characterization of copy-number variations in NR5A1 in 46, XY disorders of sex development and premature ovarian failure. Am J Med Genet 161A:2487–2494
Ehret JK et al (2015) Microdeletions in 9q33.3-q34.11 in five patients with intellectual disability, microcephaly, and Epilepsy of incomplete penetrance: is STXBP1 not the only causative gene? Mol Cytogenet 8:72. doi:10.1186/s13039-015-0178-8
Saitsu H et al (2012) Association of genomic deletions in the STXBP1 gene with Ohtahara syndrome. (Letter). Clin Genet 81:399–402
Amarillo IE et al (2015) De novo 9q gain in an infant with tetralogy of Fallot with absent pulmonary valve: Patient report and review of congenital heart disease in 9q duplication syndrome. Am J Med Genet A 167:2966–2974
Kleefstra T et al (2009) Further clinical and molecular delineation of the 9q subtelomeric deletion syndrome supports a major contribution of EHMT1 haploinsufficiency to the core phenotype. J Med Genet 46:598–606
Eggert M et al (2016) A new familial case of microdeletion syndrome 10p15.3. Eur J Med Genet 59:179–182
Vargiami E et al (2014) Severe clinical presentation in monozygotic twins with 10p15.3 microdeletion syndrome. Am J Med Genet A 164A:764–768
Melis D et al (2012) Clinical description of a patient carrying the smallest reported deletion involving 10p14 region. Am J Med Genet A 158A:832–835
Hasegawa T et al (1997) HDR syndrome (hypoparathyroidism, sensorineural deafness, renal dysplasia) associated with del(10)(p13). Am J Med Genet 73:416–418
Schilter KF et al (2015) Identification of an Alu-repeat-mediated deletion of OPTN upstream region in a patient with a complex ocular phenotype. Mol Genet Genomic Med 3:490–499
Okamoto N et al (2012) Deletion at chromosome 10p11.23-p12.1 defines characteristic phenotypes with marked midface retrusion. J Hum Genet 57:191–196
Mroczkowski HJ et al (2014) Interstitial 10p11.23-p12.1 microdeletions associated with developmental delay, craniofacial abnormalities, and cryptorchidism. Am J Med Genet A 164A:2623–2626
DeSanto C et al (2015) WAC loss-of-function mutations cause a recognizable syndrome characterised by dysmorphic features, developmental delay and hypotonia and recapitulate 10p11.23 microdeletion syndrome. J Med Genet 52:754–761
Wentzel C et al (2011) Genomic and clinical characteristics of six patients with partially overlapping interstitial deletions at 10p12p11. Europ J Hum Genet 19:959–964
Sosoi S et al (2015) Prenatal and postnatal findings in a 10.6 Mb interstitial deletion at 10p11.22-p12.31. J Hum Genet 60:183–185
Martucciello G et al (1992) Total colonic aganglionosis with interstitial deletion of the long arm of chromosome 10. Pediat Surg Int 7:308–310
Chen CP et al (2012) Prenatal diagnosis of an interstitial deletion of 10q (10q11.21 → q21.1): array comparative genomic hybridization characterization and literature review. Taiwan J Obstet Gynecol 51:672–676
Stankiewicz P et al (2012) Recurrent deletions and reciprocal duplications of 10q11.21q11.23 including CHAT and SLC18A3 are likely mediated by complex low-copy repeats. Hum Mutat 33:165–179
Babovic N et al (2010) Mucinous cystadenoma of ovary in a patient with juvenile polyposis due to 10q23 microdeletion: expansion of phenotype. Am J Med Genet 152A:2623–2627
Delnatte C et al (2006) Contiguous gene deletion within chromosome arm 10q is associated with juvenile polyposis of infancy, reflecting cooperation between the BMPR1A and PTEN tumor-suppressor genes. Am J Hum Genet 78:1066–1074
Alimi A et al (2015) Overlap of Juvenile polyposis syndrome and Cowden syndrome due to de novo chromosome 10 deletion involving BMPR1A and PTEN: implications for treatment and surveillance. Am J Med Genet A 167:1305–1308
Dimitrov BI et al (2010) Distal limb deficiencies, micrognathia syndrome, and syndromic forms of split hand foot malformation (SHFM) are caused by chromosome 10q genomic rearrangements. J Med Genet 47:103–111
Miller ND et al (2009) Molecular (SNP) analyses of overlapping hemizygous deletions of 10q25.3 to 10qter in four patients: evidence for HMX2 and HMX3 as candidate genes in hearing and vestibular function. Am J Med Genet 149A:669–680
Tanteles GA et al (2015) Mild phenotype in a patient with a de novo 6.3 Mb distal deletion at 10q26.2q26.3. Case Rep Genet 242891. doi:10.1155/2015/242891
Choucair N et al (2015) 10q26.1 microdeletion: redefining the critical regions for microcephaly and genital defects. Am J Med Genet A 167A:2707–2713
Sparago A et al (2004) Microdeletions in the human H19 DMR result in loss of IGF2 imprinting and Beckwith-Wiedemann syndrome. Nat Genet 36:958–960
Zollino M et al (2010) A case of Beckwith-Wiedemann syndrome caused by a cryptic 11p15 deletion encompassing the centromeric imprinted domain of the BWS locus. J Med Genet 47:429–432
Vals MA et al (2015) Familial 1.3-Mb 11p15.5p15.4 Duplication in three generations causing Silver-Russell and Beckwith-Wiedemann Syndromes. Mol Syndromol 6:147–151
Brown LA et al (2014) Cryptic familial rearrangement of 11p15.5, involving both imprinting centers, in a family with a history of short stature. Am J Med Genet A 164A:1587–1594
Tezcan B, Rich P, Bhide A (2015) Prenatal diagnosis of WAGR syndrome. Case Rep Obstet Gynecol 2015:928585. doi:10.1155/2015/928585
Seabra CM et al (2014) A novel Alu-mediated microdeletion at 11p13 removes WT1 in a patient with cryptorchidism and azoospermia. Reprod Biomed Online 29:388–391. doi:10.1016/j.rbmo.2014.04.017
Yi T et al (2014) GR4/GPR48 inactivation leads to aniridia-genitourinary defects-mental retardation syndrome defects. J Biol Chem 289:8767–8780
Hu P et al (2015) A novel 11p13 microdeletion encompassing PAX6 in a Chinese Han family with aniridia, ptosis and mental retardation. Mol Cytogenet 8(1):3. doi:10.1186/s13039-015-0110-2
Bremond-Gignac D et al (2005) Combination of WAGR and Potocki-Shaffer contiguous deletion syndromes in a patient with an 11p11.2-p14 deletion. Europ J Hum Genet 13:409–413
Chuang L et al (2005) Interstitial deletion 11(p11.12p11.2) and analphoid marker formation results in inherited Potocki-Shaffer syndrome. Am J Med Genet 133A:180–183
Swarr DT et al (2010) Potocki-Shaffer syndrome: comprehensive clinical assessment, review of the literature, and proposals for medical management. Am J Med Genet 152A:565–572
Gregory-Evans CY et al (2007) SNP genome scanning localizes oto-dental syndrome to chromosome 11q13 and microdeletions at this locus implicate FGF3 in dental and inner-ear disease and FADD in ocular coloboma. Hum Molec Genet 16:2482–2493
Narumi S et al (2010) Various types of LRP5 mutations in four patients with osteoporosis-pseudoglioma syndrome: identification of a 7.2-kb microdeletion using oligonucleotide tiling microarray. Am J Med Genet 152A:133–140
Bernaciak J et al (2008) Clinical and molecular-cytogenetic evaluation of a family with partial Jacobsen syndrome without thrombocytopenia caused by an ~5 Mb deletion del(11)(q24.3). Am J Med Genet 146A:2449–2454
Coldren CD et al (2009) Chromosomal microarray mapping suggests a role for BSX and neurogranin in neurocognitive and behavioral defects in the 11q terminal deletion disorder(Jacobsen syndrome). Neurogenetics 10:89–95
Vermeesch JR et al (2005) Tetrasomy 12pter-12p13.31 in a girl with partial Pallister-Killian syndrome phenotype. Eur J Med Genet 48:319–327
Theisen A et al (2009) aCGH detects partial tetrasomy of 12p in blood from Pallister-Killian syndrome cases without invasive skin biopsy. Am J Med Genet A 149A:914–917
Fanizza I et al (2014) Genotype-phenotype relationship in a child with 2.3 Mb de novo interstitial 12p13.33-p13.32 deletion. Eur J Med Genet 57:334–338
Silva IM et al (2014) A 1.5 Mb terminal deletion of 12p associated with autism spectrum disorder. Gene 542:83–86
Thevenon J et al (2013) 12p13.33 microdeletion including ELKS/ERC1, a new locus associated with childhood apraxia of speech. Eur J Hum Genet 21:82–88
Carlsen EØ et al (2015) Haploinsufficiency of ANO6, NELL2 and DBX2 in a boy with intellectual disability and growth delay. Am J Med Genet A 167A:1890–1896
Adam MP et al (2010) A family with a 1.17 Mb deletion of 12q12: refining genotype-phenotype correlation. Am J Med Genet A 152A:2394–2398
Wilson BT et al (2013) Interstitial microduplication 12q13.2-q13.3 in a patient with dysmorphism, developmental delay, atypical epilepsy and hypospadias: not a phenocopy of Wolf-Hirschhorn syndrome. Am J Med Genet A. 161A:2004–2008
Bertoli M et al (2013) Another patient with 12q13 microduplication. Am J Med Genet A 161A:2004–2008
Mc Cormack A et al (2015) 12q14 microdeletions: additional case series with confirmation of a macrocephaly Region. Case Rep Genet 2015:192071. doi:10.1155/2015/192071
Takenouchi T et al (2012) 12q14 microdeletion syndrome and short stature with or without relative macrocephaly. Am J Med Genet A 158A:2542–2544
Mari F et al (2009) Refinement of the 12q14 microdeletion syndrome: primordial dwarfism and developmental delay with or without osteopoikilosis. Eur J Hum Genet 17:1141–1147
Alyaqoub F et al (2012) 12q14 microdeletion associated with HMGA2 gene disruption and growth restriction. Am J Med Genet A 158A:2925–2930
Oliveira R et al (2015) 12q21.2q22 deletion: a new patient. Am J Med Genet A 167A:1877–1883
Shchelochkov OA et al (2008) Duplication of chromosome band 12q24.11q24.23 results in apparent Noonan syndrome. Am J Med Genet A 146A:1042–1048
Palumbo O et al (2015) Microdeletion of 12q24.31: report of a girl with intellectual disability, stereotypies, Epilepsy and facial dysmorphisms. Am J Med Genet A 167A:438–444
Verhoeven WM et al (2015) A 12q24.31 interstitial deletion in an adult male with MODY3: neuropsychiatric and neuropsychological characteristics. Am J Med Genet A 167A:169–173
Lesnik Oberstein SAJ et al (2006) Peters plus syndrome is caused by mutations in B3GALTL, a putative glycosyltransferase. Am J Hum Genet 79:562–566
Caselli R et al (2007) Retinoblastoma and mental retardation microdeletion syndrome: clinical characterization and molecular dissection using array CGH. J Hum Genet 52:535–542
de Pontual L et al (2011) Germline deletion of the miR-17-92 cluster causes skeletal and growth defects in humans. Nat Genet 43:1026–1030
Teszas A et al (2006) Expanding the clinical spectrum of MYCN-related Feingold syndrome. Am J Med Genet 140A:2254–2256
Solomon BD et al (2010) Mutations in human holoprosencephaly: description of a novel ZIC2 specific phenotype and comprehensive analysis of 157 individuals. J Med Genet 47:513–524
Huang C et al (2012) Congenital heart defect and mental retardation in a patient with a 13q33.1-34 deletion. Gene 498:308–310
Walczak-Sztulpa J et al (2008) Chromosome deletions in 13q33-34: report of four patients and review of the literature. Am J Med Genet A 146A:337–342
Witters I et al (2009) Chabchoub E, Vermeesch JR, Fryns JP. Submicroscopic distal deletion of the long arm of chromosome 13(13q34) with corpus callosum agenesis. Am J Med Genet A 149A:1834–1836
Yang YF et al (2013) A 1.1 Mb deletion in distal 13q deletion syndrome region with congenital heart defect and postaxial polydactyly: additional support for a CHD locus at distal 13q34 region. Gene 528:51–54
Zollino M et al (2009) The ring 14 syndrome: clinical and molecular definition. Am J Med Genet A 149A:1116–1124
Drabova J et al (2015) Long term follow-up in a patient with a de novo microdeletion of 14q11.2 involving CHD8. Am J Med Genet A 167A:837–841
Prontera P et al (2014) Recurrent ∼100 Kb microdeletion in the chromosomal region 14q11.2, involving CHD8 gene, is associated with autism and macrocephaly. Am J Med Genet A 164A:3137–3141
Terrone G et al (2014) A case of 14q11.2 microdeletion with autistic features, severe obesity and facial dysmorphisms suggestive of Wolf-Hirschhorn syndrome. Am J Med Genet A 164A:190–193
Zahir F et al (2007) Novel deletions of 14q11.2 associated with developmental delay, cognitive impairment and similar minor defects in three children. J Med Genet 44:556–561
Monfort S et al (2007) Duplication of 14q11.2 associates with short stature and mild mental retardation: a putative relation with quantitative trait loci. Am J Med Genet A 143:382–384
Torgyekes E et al (2011) The proximal chromosome 14q microdeletion syndrome: delineation of the phenotype using high resolution SNP oligonucleotide microarray analysis (SOMA) and review of the literature. Am J Med Genet A 155A:1884–1896
Wannenmacher B et al (2015) A 33-year-old male patient with paternal derived duplication of 14q11.2-14q22.1~22.3: clinical course, phenotypic and genotypic findings. J Pediatr Endocrinol Metab 29:611–616
Piccione M et al (2012) 14q13.1-21.1 deletion encompassing the HPE8 locus in an adolescent with intellectual disability and bilateral microphthalmia, but without holoprosencephaly. Am J Med Genet A 158A:1427–1433
Kamnasaran D et al (2005) Defining a holoprosencephaly locus on human chromosome 14q13 and characterization of potential candidate genes. Genomics 85:608–621
North KN et al (1995) CHARGE association in a child with de novo inverted duplication (14)(q22-q24.3). Am J Med Genet 57:610–614
Gimelli S et al (2013) Interstitial deletion 14q31.1q31.3 transmitted from a mother to her daughter, both with features of hemifacial microsomia. J Appl Genet 54:361–365
Severi G et al (2016) New patients with Temple syndrome caused by 14q32 deletion: genotype-phenotype correlations and risk of thyroid cancer. Am J Med Genet A 170:162–169
Youngs EL, Dasouki M, Butler MG (2012) 14q32 deletion syndrome: a clinical report. Clin Dysmorphol 21:42–44
Béna F et al (2010) Current 14q32.2 microdeletion mediated by expanded TGG repeats. Hum Mol Genet 19:1967–1973
Zada A et al (2014) A rare, recurrent, de novo 14q32.2q32.31 microdeletion of 1.1 Mb in a 20-year-old female patient with a maternal UPD(14)-like phenotype and intellectual disability. Case Rep Genet 2014:530134. doi:10.1155/2014/530134
Beygo J et al (2014) Novel deletions affecting the MEG3-DMR provide further evidence for a hierarchical regulation of imprinting in14q32. Eur J Hum Genet 23:180–188
Rosenfeld JA et al (2015) Clinical features associated with copy number variations of the 14q32 imprinted gene cluster. Am J Med Genet A 167A:345–353
Corsello G et al (2015) Paternal uniparental disomy chromosome 14-like syndrome due a maternal de novo 160 kb deletion at the 14q32.2 region not encompassing the IG- and the MEG3-DMRs: patient report and genotype-phenotype correlation. Am J Med Genet A 167A:3130–3138
Thiel CT et al (2008) A de novo 7.6 Mb tandem duplication of 14q32.2-qter associated with primordial short stature with neurosecretory growth hormone dysfunction, distinct facial defects and mild developmental delay. Eur J Med Genet 51:362–367
Salter CG et al (2016) Expanding the ocular phenotype of 14q terminal deletions: a novel presentation of microphthalmia and coloboma in ring 14 syndrome with associated 14q32.31 deletion and review of the literature. Am J Med Genet A 170A:1017–1022
Ortigas AP et al (1997) Delineation of 14q32.3 deletion syndrome. J Med Genet 34:515–517
Meschede D et al (1998) Submicroscopic deletion in 14q32.3 through a de novo tandem translocation between 14q and 21p. Am J Med Genet A 80A:443–447
Ting TW et al (2016) DICER1 deletion and 14q32 microdeletion syndrome: an additional case and a review of the literature. Clin Dysmorphol 25:37–40
Merritt JL 2nd et al (2001) 5) 14q32.3 deletion syndrome with autism. Am J Med Genet A 133A:99–100
Burnside RD et al (2011) Microdeletion/microduplication of proximal 15q11.2 between BP1 and BP2: a susceptibility region for neurological dysfunction including developmental and language delay. Hum Genet 130:517–528
von der Lippe C et al (2015) 15q11.2 microdeletion—seven new patients with delayed development and/or behavioural problems. Europ J Med Genet 54:357–360
Cox DM, Butler MG (2015) The 15q11.2 BP1-BP2 microdeletion syndrome: a review. Int J Mol Sci 16:4068–4082
Jerkovich AM, Butler MG (2014) Further phenotypic expansion of 15q11.2 BP1-BP2 microdeletion (Burnside-Butler) syndrome. J Pediatr Genet 3:41–44
Vanlerberghe C et al (2015) 15q11.2 microdeletion (BP1-BP2) and developmental delay, behaviour issues, epilepsy and congenital heart disease: a series of 52 patients. Eur J Med Genet 58:140–147
Noor A et al (2015) 15q11.2 duplication encompassing only the UBE3A gene is associated with developmental delay and neuropsychiatric phenotypes. Hum Mutat 36:689–693
Kalsner L, Chamberlain SJ (2015) Prader-Willi, Angelman, and 15q11-q13 duplication syndromes. Pediatr Clin North Am 62:587–606
Miller DT et al (2009) Microdeletion/duplication at 15q13.2q13.3 among individuals with features of autism and other neuropsychiatric disorders. J Med Genet 46:242–248
Riikonen RS, Wallden T, Kokkonen H. Infantile spasms and 15q11.2q13.1 chromosome duplication in two successive generations. Eur J Paediatr Neurol 20:164–167
Burrage LC et al (2012) De novo interstitial duplication of 15q11.2-q13.1 with complex maternal uniparental trisomy for the 15q11-q13 region in a patient with Prader-Willi syndrome. Am J Med Genet A 158A:2557–2563
Cassidy SB, Schwartz S (1998) Prader-Willi and Angelman syndromes: disorders of genomic imprinting. Medicine 77:140–151
Magenis RE et al (1990) Comparison of the 15q deletions in Prader-Willi and Angelman syndromes: specific regions, extent of deletions, parental origin, and clinical consequences. Am J Med Genet 35:333–349
Smith A et al (1996) Clinical features in 27 patients with Angelman syndrome resulting from DNA deletion. J Med Genet 33:107–112
Zhou D et al (2016) 15q13.3 duplication in two patients with childhood-onset schizophrenia. Am J Med Genet B Neuropsychiatr Genet. 2016 Mar 10. doi:10.1002/ajmg.b.32439 [Epub ahead of print-not out yet]
Ben-Shacher S et al (2009) Microdeletion 15q13.3: a locus with incomplete penetrance for autism, mental retardation, and psychiatric disorders. J Med Genet 46:382–388
Sharp AJ et al (2008) A recurrent 15q13.3 microdeletion syndrome associated with mental retardation and epilepsy. Nat Genet 40:322–328
Lowther C et al (2015) Delineating the 15q13.3 microdeletion phenotype: a case series and comprehensive review of the literature. Genet Med 17:149–157
Yuan H et al (2016) A rare de novo interstitial duplication of 15q15.3q21.2 in a boy with severe short stature, hypogonadism, global developmental delay and intellectual disability. Mol Cytogenet 9:2. doi:10.1186/s13039-016-0214-3
El-Hattab AW et al (2009) (2009 Redefined genomic architecture in 15q24 directed by patient deletion/duplication breakpoint mapping. Hum Genet 126:589–602
Sharp AJ et al (2007) Characterization of a recurrent 15q24 microdeletion syndrome. Hum Molec Genet 16:567–572
Burgess T et al (2014) Characterization of core clinical phenotypes associated with recurrent proximal 15q25.2 microdeletions. Am J Med Genet 164A:77–86
Cooper GM et al (2011) A copy number variation morbidity map of developmental delay. Nat Genet 43:838–846
Doelken SC et al (2013) Proximal and distal 15q25.2 microdeletions: genotype-phenotype delineation of two neurodevelopmental susceptibility loci. Am J Med Genet 161A:218–224
Poot M et al (2013) Variable behavioural phenotypes of patients with monosomies of 15q26 and a review of 16 cases. Eur J Med Genet 56:346–350
Kamien B et al (2015) Characterization of a 520 kb deletion on chromosome 15q26.1 including ST8SIA2 in a patient with behavioral disturbance, autism spectrum disorder, and epilepsy: additional information. Am J Med Genet A 167:1424 only
Courage C et al (2014) 15q26.1 microdeletion encompassing only CHD2 and RGMA in two adults with moderate intellectual disability, epilepsy and truncal obesity. Eur J Med Genet 57:520–523
Leffler M et al (2015) Two familial microduplications of 15q26.3 causing overgrowth and variable intellectual disability with normal copy number of IGF1R. Eur J Med Genet 59:257–262
Rump P et al (2008) Drayer’s syndrome of mental retardation, microcephaly, short stature and absent phalanges is caused by a recurrent deletion of chromosome 15(q26.2-qter). Clin Genet 74:455–462
Veenma DCM et al (2010) Phenotype-genotype correlation in a familial IGF1R microdeletion case. J Med Genet 47:492–498
Reutlinger C et al (2010) Deletions in 16p13 including GRIN2A in patients with intellectual disability, various dysmorphic features, and seizure disorders of the rolandic region. Epilepsia 51:1870–1873
Harteveld CL et al (2007) Refinement of the genetic cause of ATR-16. Hum Genet 122:283–292
Gibson WT et al (2008) Phenotype-genotype characterization of alpha-thalassemia mental retardation syndrome due to isolated monosomy of 16p13.3. Am J Med Genet 146A:225–232
Bartsch O et al (2002) Molecular studies in 10 cases of Rubinstein-Taybi syndrome, including a mild variant showing a missense mutation in codon 1175 of CREBBP. J Med Genet 39:496–501
Gervasini C et al (2007) High frequency of mosaic CREBBP deletions in Rubinstein-Taybi syndrome patients and mapping of somatic and germ-line breakpoints. Genomics 90:567–573
Taine L et al (1998) Submicroscopic deletion of chromosome 16p13.3 in patients with Rubinstein-Taybi syndrome. Am J Med Genet 78:267–270
Houcinat N et al (2015) Homozygous 16p13.11 duplication associated with mild intellectual disability and urinary tract malformations in two siblings born from consanguineous parents. Am J Med Genet A 167A:2714–2719
Brownstein CA et al (2016) Overlapping 16p13.11 deletion and gain of copies variations associated with childhood onset psychosis include genes with mechanistic implications for autism associated pathways: two case reports. Am J Med Genet A 170A:1165–1173
Miteff CI et al (2015) 16p13.11 microdeletion in a patient with hemiconvulsion-hemiplegia-epilepsy syndrome: a case report. J Child Neurol 30:83–86
Girirajan S et al (2010) A recurrent 16p12.1 microdeletion supports a two-hit model for severe developmental delay. Nat Genet 42:203–209
Antonacci F et al (2010) A large and complex structural polymorphism at 16p12.1 underlies microdeletion disease risk. Nat Genet 42:745–750
Rai B, Sharif F (2015) Cervicomedullary spinal stenosis and ventriculomegaly in a child with developmental delay due to chromosome16p12.1 microdeletion syndrome. J Child Neurol 30:394–396
Ballif BC et al (2007) Discovery of a previously unrecognized microdeletion syndrome of 16p11.2-p12.2. Nat Genet 39:1071–1073
Hempel M et al (2009) Microdeletion syndrome 16p11.2-p12.2: clinical and molecular characterization. Am J Med Genet A 149A:2106–2112
Battaglia A et al (2009) Further characterization of the new microdeletion syndrome of 16p11.2-p12.2. Am J Med Genet 149A:1200–1204
Maillard AM et al (2015) 16p11.2 locus modulates response to satiety before the onset of obesity. Int J Obes (Lond) 40:870–876
Berman JI et al (2016) Relationship between M100 auditory evoked response and auditory radiation microstructure in 16p11.2 deletion and duplication carriers. Am J Neuroradiol Feb 11 [Epub ahead of print]
Hippolyte L et al (2015) The number of genomic copies at the 16p11.2 locus modulates language, Verbal Memory, and Inhibition. Biol Psychiatry http://dx.doi.org/10.1016/j.biopsych.2015.10.021 pii:S0006-3223(15)00917-8
Bachmann-Gagescu R et al (2010) Recurrent 200-kb deletions of 16p11.2 that include the SH2B1 gene are associated with developmental delay and obesity. Genet Med 12:641–647
Sampson MG et al (2010) Evidence for a recurrent microdeletion at chromosome 16p11.2 associated with congenital defects of the kidney and urinary tract (CAKUT) and Hirschsprung disease. Am J Med Genet 152A:2618–2622
Shinawi M et al (2010) Recurrent reciprocal 16p11.2 rearrangements associated with global developmental delay, behavioural problems, dysmorphism, epilepsy, and abnormal head size. J Med Genet 47:332–341
Fernandez BA et al (2010) Phenotypic spectrum associated with de novo and inherited deletions and duplications at 16p11.2 in individuals ascertained for diagnosis of autism spectrum disorder. J Med Genet 47:195–203
Morisada N et al (2014) 16q12 microdeletion syndrome in two Japanese boys. Pediatr Int 56(5):e75–e78. doi:10.1111/ped.12426
Shoukier M et al (2012)16q12 microdeletion in a boy with severe psychomotor delay, craniofacial dysmorphism, brain and limb malformations, and a heart defect. Am J Med Genet A 158A):229–235
Chang CF et al (2010) Identification of a submicroscopic 3.2 Mb chromosomal 16q12.2-13 deletion in a child with short stature, mild developmental delay, and craniofacial defects, by high-density oligonucleotide array-a recognizable syndrome. Am J Med Genet A 152A:2365–2371
Jobling RK et al (2013) The first report of nephrocalcinosis in a patient with a 16q23.1-16q23.3 deletion, global developmental delay, trigonocephaly, and portocaval shunt. Clin Dysmorphol 22:152–155000007
Van der Aa N et al (2012) Haploinsufficiency of CMIP in a girl with autism spectrum disorder and developmental delay due to a de novo deletion on chromosome 16q23.2. Autism Res 5:277–281
Dello Russo P et al (2015) A 16q deletion involving FOXF1 enhancer is associated to pulmonary capillary hemangiomatosis. BMC Med Genet 16:94. doi:10.1186/s12881-015-0241-7
Stankiewicz P et al (2009) Genomic and genic deletions of the FOX gene cluster on 16q24.1 and inactivating mutations of FOXF1 cause alveolar capillary dysplasia and other malformations. Am J Hum Genet 84:780–791
Yu S et al (2010) Haploinsufficiencies of FOXF1 and FOXC2 genes associated with lethal alveolar capillary dysplasia and congenital heart disease. Am J Med Genet 152A:1257–1262
Quéméner-Redon S et al (2013) A small de novo 16q24.1 duplication in a woman with severe clinical features. Eur J Med Genet 56:211–215
Dharmadhikari AV et al (2014) Molecular and clinical analyses of 16q24.1 duplications involving FOXF1 identify an evolutionarily unstable large minisatellite. BMC Med Genet 15:128. doi:10.1186/s12881-014-0128-z
Garabedian MJ et al (2012) Prenatal diagnosis of cystic hygroma related to a deletion of 16q24.1 with haploinsufficiency of FOXF1 and FOXC2 genes. Case Rep Genet 2012:490408. doi:10.1155/2012/490408
Smith AW et al (2015) Deletion of 16q24.1 supports a role for the ATP2C2 gene in specific language impairment. J Child Neurol 30:517–521. doi:10.1177/0883073814545113
Seeley AH et al (2014) Macrocerebellum, epilepsy, intellectual disability, and gut malrotation in a child with a 16q24.1-q24.2 contiguous gene deletion. Am J Med Genet A 164A:2062–2068
Handrigan GR et al (2013) Deletions in 16q24.2 are associated with autism spectrum disorder, intellectual disability and congenital renal malformation. J Med Genet 50:163–173
Grønborg S et al (2015) Monozygotic twins with a de novo 0.32 Mb 16q24.3 deletion, including TUBB3 presenting with developmental delay and mild facial dysmorphism but without overt brain malformation. Am J Med Genet A 167A:2731–2736
Kim HJ et al (2015) A Korean family with KBG syndrome identified by ANKRD11 mutation, and phenotypic comparison of ANKRD11 mutation and 16q24.3 microdeletion. Eur J Med Genet 58:86–94
Khalifa M et al (2013) Partial deletion of ANKRD11 results in the KBG phenotype distinct from the 16q24.3 microdeletion syndrome. Am J Med Genet A 161A:835–840
Miyatake S et al (2013) A de novo deletion at 16q24.3 involving ANKRD11 in a Japanese patient with KBG syndrome. Am J Med Genet A 161A:1073–1077
Allanson JE, Ledbetter DH, Dobyns WB. Classical lissencephaly syndromes: does the face reflect the brain? J Med Genet 35:920–923
Bruno DL et al (2010) Further molecular and clinical delineation of co-locating 17p13.3 microdeletions and microduplications that show distinctive phenotypes. J Med Genet 47:299–311
Nagamani SC et al (2009) Microdeletions including YWHAE in the Miller-Dieker syndrome region on chromosome 17p13.3 result in facial dysmorphisms, growth restriction, and cognitive impairment. J Med Genet 46:825–833
Schiff M et al (2010) Further delineation of the 17p13.3 microdeletion involving YWHAE but distal to PAFAH1B1: four additional patients. Eur J Med Genet 53:303–308
Armour CM et al (2011) 17p13.3 microduplications are associated with split-hand/foot malformation and long-bone deficiency (SHFLD). Europ J Hum Genet 19:1144–1151
Tucker ME, Escobar LF (2014) Cleft lip/palate associated with 17p13.3 duplication involving a single candidate gene (YWHAE). Clin Genet 85:600–601
Capra V et al (2012) Identification of a rare 17p13.3 duplication including the BHLHA9 and YWHAE genes in a family with developmental delay and behavioural problems. BMC Med Genet 13:93. doi:10.1186/1471-2350-13-93
Curry CJ et al (2013) The duplication 17p13.3 phenotype: analysis of 21 families delineates developmental, behavioral and brain abnormalities, and rare variant phenotypes. Am J Med Genet A 161A:1833–1852
Ho AC et al (2012) A newborn with a 790 kb chromosome 17p13.3 microduplication presenting with aortic stenosis, microcephaly and dysmorphic facial features - is cardiac assessment necessary for all patients with 17p13.3 microduplication? Eur J Med Genet 55:758–762
Bi W et al (2009) Increased LIS1 expression affects human and mouse brain development. Nat Genet 41:168–177
Roos L et al (2009) A new microduplication syndrome encompassing the region of the Miller-Dieker (17p13 deletion) syndrome. J Med Genet 46:703–710
Ho G et al (2011) Maternal riboflavin deficiency, resulting in transient neonatal-onset glutaric aciduria type 2, is caused by a microdeletion in the riboflavin transporter gene GPR172B. Hum Mutat 32:E1976–E1984
Kuroda Y et al (2014) De novo duplication of 17p13.1-p13.2 in a patient with intellectual disability and obesity. Am J Med Genet A 164A:1550–1554
Coutton C et al (2012) 17p13.1 microduplication in a boy with Silver-Russell syndrome features and intellectual disability. Am J Med Genet A 158A:2564–2570
Zeesman S et al (2012) Microdeletion in distal 17p13.1: a recognizable phenotype with microcephaly, distinctive facial features, and intellectual disability. Am J Med Genet A 158A:1832–1836
Giordano L et al (2012) 17p13.1 microdeletion: genetic and clinical findings in a new patient with epilepsy and comparison with literature. Am J Med Genet A 164A:225–230
Schluth-Bolard C et al (2010) 17p13.1 microdeletioninvolving the TP53 gene in a boy presenting with mental retardation but no tumor. Am J Med Genet 152A:1278–1282
Shlien A et al (2010) A common molecular mechanism underlies two phenotypically distinct 17p13.1 microdeletion syndromes. Am J Hum Genet 87:631–642
Lupski JR et al (1991) DNA duplication associated with Charcot-Marie-Tooth disease type 1A. Cell 66:219–232
Zhang F et al (2010) Mechanisms for nonrecurrent genomic rearrangements associated with CMT1A or HNPP: rare CNVs as a cause for missing heritability. Am J Hum Genet 86:892–903
Chance PF et al (1993) DNA deletion associated with hereditary neuropathy with liability to pressure palsies. Cell 72:143–151
Chen K-S et al (1997) Homologous recombination of a flanking repeat gene cluster is a mechanism for a common contiguous gene deletion syndrome. Nature Genet 17:154–163
Edelman EA et al (2007) Gender, genotype, and phenotype differences in Smith-Magenis syndrome: a meta-analysis of 105 cases. Clin Genet 71:540–550
Cnossen MH et al (1997) Deletions spanning the neurofibromatosis type 1 gene: implications for genotype-phenotype correlations in neurofibromatosis type 1? Hum Mutat 9:458–464
Douglas J et al, The Childhood Overgrowth Collaboration (2007) Mutations in RNF135, a gene within the NF1 microdeletion region, causes phenotypic abnormalities including overgrowth. Nat Genet 39:963–965
Jenne DE et al (2001) Molecular characterization and gene content of breakpoint boundaries in patients with neurofibromatosis type 1 with 17q11.2 microdeletions. Am J Hum Genet 69:516–527
Visser R et al (2009) RNF135 mutations are not present in patients with Sotos syndrome-like features. Am J Med Genet A 149A:806–808
Potocki L et al (2000) Molecular mechanism for duplication 17p11.2—the homologous recombination reciprocal of the Smith-Magenis microdeletion. Nature Genet 24:84–87
Potocki L et al (2007) Characterization of Potocki-Lupski syndrome (dup(17)(p11.2p11.2)) and delineation of a dosage-sensitive critical interval that can convey an autism phenotype. Am J Hum Genet 80:633–649
Magoulas PL et al (2014) Inherited dup(17)(p11.2p11.2): expanding the phenotype of the Potocki-Lupski syndrome. Am J Med Genet A 164A:500–504
Jones GE et al (2015) Should we offer prenatal testing for 17q12 microdeletion syndrome to all cases with prenatally diagnosed echogenic kidneys? Prenatal findings in two families with17q12 microdeletion syndrome and review of the literature. Prenat Diagn 35:1336–1341
Goumy C et al (2015) Congenital diaphragmatic hernia may be associated with 17q12 microdeletion syndrome. Am J Med Genet A 167A:250–253
Bernardini L et al (2009) Recurrent microdeletion at 17q12 as a cause of Mayer-Rokitansky-Kuster-Hauser (MRKH) syndrome: two case reports. Orphanet J Rare Dis 4:25. doi:10.1186/1750-1172-4-25
Loirat C et al (2010) Autism in three patients with cystic or hyperechogenic kidneys and chromosome 17q12 deletion. Nephrol Dial Transplant 25:3430–3433
Mefford HC et al (2007) Recurrent reciprocal genomic rearrangements of 17q12 are associated with renal disease, diabetes, and epilepsy. Am J Hum Genet 81:1057–1069
Nagamani SC et al (2010) Clinical spectrum associated with recurrent genomic rearrangements in chromosome 17q12. Europ J Hum Genet 18:278–284
Caselli R et al (2010) A 12.4 Mb duplication of 17q11.2q12 in a patient with psychomotor developmental delay and minor defects. Europ J Med Genet 53:325–328
Sharp AJ et al (2006) Discovery of previously unidentified genomic disorders from the duplication architecture of the human genome. Nature Genet 38:1038–1042
Mitchell E et al (2015) Recurrent duplications of 17q12 associated with variable phenotypes. Am J Med Genet A 167:3038–3045
Koolen DA et al (2008) Clinical and molecular delineation of the 17q21.31 microdeletion syndrome. J Med Genet 45:710–720
Zollino M et al (2015) Intragenic KANSL1 mutations and chromosome 17q21.31 deletions: broadening the clinical spectrum and genotype-phenotype correlations in a large cohort of patients. J Med Genet 52:804–814
Grisart B (2009) 17q21.31 microduplication patients are characterised by behavioural problems and poor social interaction. J Med Genet 46:524–530
Kirchhoff M et al (2007) A 17q21.31 microduplication, reciprocal to the newly described 17q21.31microdeletion, in a girl with severe psychomotor developmental delay and dysmorphic craniofacial features. Europ J Med Genet 50:256–263
Natacci F et al (2016) Chromosome 17q21.31 duplication syndrome: Description of a new familiar case and further delineation of the clinical spectrum. Eur J Paediatr Neurol 20:183–187
Ballif BC et al (2010) Identification of a recurrent microdeletion at 17q23.1q23.2 flanked by segmental duplications associated with heart defects and limb abnormalities. Am J Hum Genet 86:454–461
Alvarado DM et al (2010) Familial isolated clubfoot is associated with recurrent chromosome 17q23.1q23.2 microduplications containing TBX4. Am J Hum Genet 87:154–160
Sun M et al (2009) Copy-number mutations on chromosome 17q24.2-q24.3 in congenital generalized hypertrichosis terminalis with or without gingival hyperplasia. Am J Hum Genet 84:807–813
Probst FJ et al (James RA, Burrage LC, Rosenfeld JA, Bohan TP, Ward Melver CH, Magoulas P, Austin E, Franklin AI, Azamian M, Xia F, Patel A, Bi W, Bacino C, Belmont JW, Ware SM, Shaw C, Cheung SW, Lalani SR) De novo deletions and duplications of 17q25.3 cause susceptibility to cardiovascular malformations. Orphanet J Rare Dis 10:75. doi:10.1186/s13023-015-0291-0
Hackmann K et al (2013) Severe intellectual disability, West syndrome, Dandy-Walker malformation, and syndactyly in a patient with partial tetrasomy 17q25.3. Am J Med Genet A 161A:3144–3149
Lukusa T, Fryns JP (2010) Pure de novo 17q25.3 micro duplication characterized by micro array CGH in a dysmorphic infant with growth retardation, developmental delay and distal arthrogryposis. Genet Couns 21:25–34
Srebniak MI et al (2011) Prenatally diagnosed submicroscopic familial aberrations at 18p11.32 without phenotypic effect. Mol Cytogenet 4:27. doi:10.1186/1755-8166-4-27
Verrotti A et al (2015) Deletion 18p11.32p11.31 in a child with global developmental delay and atypical, drug-resistant absence epilepsy. Cytogenet Genome Res 146:115–119
Kantaputra PN et al (2006) Contiguous gene syndrome of holoprosencephaly and hypotrichosis simplex: association with an 18p11.3 deletion. Am J Med Genet A 140:2598–2602
Bendavid C et al (2006) Molecular evaluation of foetuses with holoprosencephaly shows high incidence of microdeletions in the HPE genes. Hum Genet 119:1–8
Balasubramanian M, Sithambaram S, Smith K (2016) Inherited duplication of the short arm of chromosome 18p11.32-p11.31 associated with developmental delay/intellectual disability. Clin Dysmorphol 25:19–22
Occella C et al (2013) Identification of an interstitial 18p11.32-p11.31 duplication including the EMILIN2 gene in a family with porokeratosis of Mibelli. PLoS ONE 8(4):e61311. doi:10.1371/journal.pone.0061311
Kaciński M, Jaworek M, Skowronek-Bała B (2007) Caudal regression syndrome associated with the white matter lesions and chromosome 18p11.2 deletion. Brain Dev 29:164–166
Schramm C et al (2011) De novo duplication of 18p11.21-18q12.1 in a female with anorectal malformation. Am J Med Genet A 155A:445–449
Zweier C et al (2007) Haploinsufficiency of TCF4 causes syndromal mental retardation with intermittent hyperventilation (Pitt-Hopkins syndrome). Am J Hum Genet 80:994–1001
Kharbanda M et al (2016) Partial deletion of TCF4 in three generation family with non-syndromic intellectual disability, without features of Pitt-Hopkins syndrome. Eur J Med Genet 59:310–314
Amiel J et al (2007) Mutations in TCF4, encoding a class I basic helix-loop-helix transcription factor, are responsible for Pitt-Hopkins syndrome, a severe epileptic encephalopathy associated with autonomic dysfunction. Am J Hum Genet 80:988–993
Zayed H et al (2010) A maternally inherited chromosome 18q22.1 deletion in a male with late-presenting diaphragmatic hernia and microphthalmia-evaluation of DSEL as a candidate gene for the diaphragmatic defect. Am J Med Genet A 152A:916–923
Eudy JD et al (2010) 18q22.3 –> 18q23 deletion syndrome and cleft palate. Am J Med Genet A 152A:1046–1048
Dostal A et al (2006) Identification of 2.3-Mb gene locus for congenital aural atresia in 18q22.3 deletion: a case report analyzed by comparative genomic hybridization. Otol Neurotol 27:427–432
Margarit E et al (2012) Familial 4.8 MB deletion on 18q23 associated with growth hormone insufficiency and phenotypic variability. Am J Med Genet A 158A:611–616
Ishikawa N et al (2013) Paroxysmal periodic dystonic postures in an infant with 18q23 deletion syndrome. Neuropediatrics 44:163–166
Lirussi F et al (2007) Beckwith-Wiedemann-like macroglossia and 18q23 haploinsufficiency. Am J Med Genet A 143A:2796–2803
Feenstra I et al (2011) Disruption of teashirt zinc finger homeobox 1 is associated with congenital aural atresia in humans. Am J Hum Genet 89:813–819
López-Exposito et al (2006) Duplication 19q13-qter and deletion 19p13-pter arising from an inversion (19)(p13.3q13.3) of maternal origin. Eur J Med Genet 49:511–515
Risheg H et al (2013) Clinical comparison of overlapping deletions of 19p13.3. Am J Med Genet A 161A:1110–1116
Peddibhotla S et al (2013) Expanding the genotype-phenotype correlation in subtelomeric 19p13.3 microdeletions using high resolution clinical chromosomal microarray analysis. Am J Med Genet A 161A:2953–2963
Nowaczyk MJ et al (2014) Deletion of MAP2K2/MEK2: a novel mechanism for a RASopathy? Clin Genet 85:138–146
Al-Kateb H et al (2010) Molecular characterization of a novel, de novo, cryptic interstitial deletion on 19p13.3 in a child with a cutis aplasia and multiple congenital defects. Am J Med Genet A 152A:3148–3153
de Smith AJ et al (2011) Blakemore AI. Chromosome 19p13.3 deletion in a patient with macrocephaly, obesity, mental retardation, and behavior problems. Am J Med Genet A 155A:1192–1195
Siggberg L et al (2011) 19p13.3 aberrations are associated with dysmorphic features and deviant psychomotor development. Cytogenet Genome Res 132:8–15
Kuroda Y et al (2015) Microdeletion of 19p13.3 in a girl with Peutz-Jeghers syndrome, intellectual disability, hypotonia, and distinctive features. Am J Med Genet A 167A:389–393
Souza J et al (2011) Chromosome 19p13.3 deletion in a child with Peutz-Jeghers syndrome, congenital heart defect, high myopia, learning difficulties and dysmorphic features: clinical and molecular characterization of a new contiguous gene syndrome. Genet Mol Biol 34:557–561
Lybaek H et al (2009) An 8.9 Mb 19p13 duplication associated with precocious puberty and a sporadic 3.9 Mb 2q23.3q24.1 deletion containing NR4A2 in mentally retarded members of a family with an intrachromosomal 19p-into-19q between-arm insertion. Eur J Hum Genet 17:904–910
Ishikawa A et al (2013) Pure duplication of 19p13.3. Am J Med Genet A 161A:2300–2304
Orellana C et al (2015) Pure duplication of 19p13.3 in three members of a family with intellectual disability and literature review. Definition of a new microduplication syndrome. Am J Med Genet A 167:1614–1620
Seidel MG et al (2014) Anovel immunodeficiency syndrome associated with partial trisomy 19p13. J Med Genet 51:254–263
Shimojima K et al (2015) An association of 19p13.2 microdeletions with Malan syndrome and Chiari malformation. Am J Med Genet A 167A:724–730
Jezela-Stanek A (2016) Malan syndrome (Sotos syndrome 2) in two patients with 19p13.2 deletion encompassing NFIX gene and novel NFIX sequence variant. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 160:161–167
Malan V (2010) Distinct effects of allelic NFIX mutations on nonsense-mediated mRNA decay engender either a Sotos-like or a Marshall-Smith syndrome. Am J Hum Genet 87:189–198
Spreiz A et al (2014) Chromosomal microaberrations in patients with epilepsy, intellectual disability, and congenital defects. Clin Genet 86:361–366
Schwemmle C et al (2014) A boy with mild mental retardation, mild sensorineural hearing loss and mild facial dysmorphism caused by a19p13.2 deletion: a case report and review of the literature. Int J Pediatr Otorhinolaryngol 78:1190–1193
Wangensteen T et al (2013) De novo 19p13.2 microdeletion encompassing the insulin receptor and resistin genes in a patient with obesity and learning disability. Am J Med Genet A 161A:1480–1486
Haberlandt E et al (2012) Microdeletion 19p13.2 in an almost 5-year-old boy. Am J Med Genet A 158A:1190–1194
Lehman AM et al (2012) 19p13.2 microduplication causes a Sotos syndrome-like phenotype and alters gene expression. Clin Genet 81:56–63
Tan RN et al (2015) Clinical and molecular characterization of an infant with a tandem duplication and deletion of 19p13. Am J Med Genet A 167A:1884–1889
Dolan M et al (2010) A novel microdeletion/microduplication syndrome of 19p13.13. Genet Med 12:503–511
Marangi G et al (2012) Expanding the spectrum of rearrangements involving chromosome 19: a mild phenotype associated with a19p13.12-p13.13 deletion. Am J Med Genet A 158A:888–893
Jensen DR et al (2009) A novel chromosome 19p13.12 deletion in a child with multiple congenital defects. Am J Med Genet A 149A:396–402
Nebel RA et al (2015) Reciprocal relationship between head size, and autism endophenotype, and gene dosage at 19p13.12 Points to AKAP8 and AKAP8L. PLoS ONE 10(6):e0129270. doi:10.1371/journal.pone.0129270
Draaken M et al (2013) Isolated bladder exstrophy associated with a de novo 0.9 Mb microduplication on chromosome 19p13.12. Birth Defects Res A Clin Mol Teratol 97:133–139
Bens S et al (2011) A de novo 1.1 Mb microdeletion of chromosome 19p13.11 provides indirect evidence for EPS15L1 to be a strong candidate for split hand split foot malformation. Eur J Med Genet 54:e501–e504
Thienpont B et al (2008) A complex submicroscopic chromosomal imbalance in 19p13.11 with one microduplication and two microtriplications. Eur J Med Genet 51:219–225
Gana S et al (2012) 19q13.11 cryptic deletion: description of two new cases and indication for a role of WTIP haploinsufficiency in hypospadias. Eur J Hum Genet 20:852–856
Malan V et al (2009) 19q13.11 deletion syndrome: a novel clinically recognisable genetic condition identified by array comparative genomic hybridisation. J Med Genet 46:635–640
Forzano F et al (2012) 19q13 microdeletion syndrome: further refining the critical region. Eur J Med Genet 55:429–432
Urquhart JE et al (2015) Deletion of 19q13 reveals clinical overlap with Dubowitz syndrome. J Hum Genet 60:781–785
Melo JB et al (2015) Cutis Aplasia as a clinical hallmark for the syndrome associated with 19q13.11 deletion: the possible role for UBA2 gene. Mol Cytogenet 8:21. doi:10.1186/s13039-015-0123-x
Landowski M et al (2013) Novel deletion of RPL15 identified by array-comparative genomic hybridization in Diamond-Blackfan anemia. Hum Genet 132:1265–1274
Castillo A et al (2014) 19q13.32 microdeletion syndrome: three new cases. Eur J Med Genet 57:654–658
Rose AM et al (2011) A 112 kb deletion in chromosome 19q13.42 leads to retinitis pigmentosa. Invest Ophthalmol Vis Sci 52:6597–6603
Köhn L et al (2009) Breakpoint characterization of a novel approximately 59 kb genomic deletion on 19q13.42 in autosomal-dominant retinitis pigmentosa with incomplete penetrance. Eur J Hum Genet 17:651–655
Abu-Amero KK et al (2015) Partial duplication of chromosome 19 associated with syndromic duane retraction syndrome. Ophthalmic Genet 36:14–20
Tadaki H et al (2011) De novo 19q13.42 duplications involving NLRP gene cluster in a patient with systemic-onset juvenile idiopathic arthritis. J Hum Genet 56:343–347
Carvalheira G et al (2014) 19q13.33→qter trisomy in a girl with intellectual impairment and Epilepsy. Meta Gene 2:799–806. doi:10.1016/j.mgene.2014.09.004
An Y et al (2013) SOX12 and NRSN2 are candidate genes for 20p13 subtelomeric deletions associated with developmental delay. Am J Med Genet B Neuropsychiatr Genet 162B:832–840
Eggermann T et al (2014) Isolated hypermethylation of GRB10 (7p12.2) in a Silver-Russell syndrome patient carrying a 20p13microdeletion. Clin Genet 85:399–400
Moutton S et al (2012) Dysmorphic features in subtelomeric 20p13 deletion excluding JAG1: a recognizable microdeletion phenotype? Eur J Med Genet 55:151–155
Jezela-Stanek A et al (2013) 1.15 Mb microdeletion in chromosome band 20p13 associated with moderate developmental delay-additional case and data’s review. Am J Med Genet A 161A:172–178
Poduri A et al (2012) Homozygous PLCB1 deletion associated with malignant migrating partial Epilepsy in infancy. Epilepsia 53:e146–e150. doi:10.1111/j.1528-1167.2012.03538.x
Leprêtre F et al (2001) Molecular and cytogenetic characterisation of a small interstitial de novo 20p13–>p12.3 deletion in a patient with severe growth deficit. Cytogenet Cell Genet 94:142–146
Leclercq S et al (2009) Molecular cytogenetic characterization of the first reported case of inv dup del 20p compatible with a U-type exchange model. Am J Med Genet A 149A:437–445
Su P et al (2011) A 4.6 kb genomic duplication on 20p12.2-12.3 is associated with brachydactyly type A2 in a Chinese family. J Med Genet 48:312–316
Liu X et al (2014) Identification of duplication downstream of BMP2 in a Chinese family with brachydactyly type A2 (BDA2). PLoS ONE 9(4):e94201. doi:10.1371/journal.pone.0094201
Dathe K et al (2009) Duplications involving a conserved regulatory element downstream of BMP2 are associated with brachydactyly type A2. Am J Hum Genet 84:483–492
Mills KI et al (2013) Duplication of 20p12.3 associated with familial Wolff-Parkinson-White syndrome. Am J Med Genet A 161A:137–144
Lalani SR et al (2009) 20p12.3 microdeletion predisposes to Wolff-Parkinson-White syndrome with variable neurocognitive deficits. J Med Genet 46:168–175
Amasdl S et al (2016) 20p12.3 deletion is rare cause of syndromic cleft palate: case report and review of literature. BMC Res Notes 9(1):5. doi:10.1186/s13104-015-1828-y
Sahoo T et al (2011) Microdeletion 20p12.3 involving BMP2 contributes to syndromic forms of cleft palate. Am J Med Genet A 155A:1646–1653
Williams ES et al (2012) Cleft palate in a multigenerational family with a microdeletion of 20p12.3 involving BMP2. Am J Med Genet A 158A:2616–2620
Legius E et al (1990) Alagille syndrome (arteriohepatic dysplasia) and del(20)(p11.2). Am J Med Genet 35:532–535
Zhang F et al (1990) Interstitial deletion of the short arm of chromosome 20 in arteriohepatic dysplasia (Alagille syndrome). J Pediat 116:73–77
Robert ML et al (2007) Alagille syndrome with deletion 20p12.2-p12.3 and hypoplastic left heart. Clin Dysmorphol 16:241–246
Krantz ID et al (1997) Deletions of 20p12 in Alagille syndrome: frequency and molecular characterization. Am J Med Genet 70:80–86
Avila M et al (2013) Delineation of a new chromosome 20q11.2 duplication syndrome including the ASXL1 gene. Am J Med Genet A 161A:1594–1598
Gervasini C et al (2013) Genomic imbalances in patients with a clinical presentation in the spectrum of Cornelia de Lange syndrome. BMC Med Genet 14:41. doi:10.1186/1471-2350-14-41
Wanderley HY et al (2005) Report of a patient with a trisomy of chromosome region 20q11.2–>20q12 and characterization with FISH. Genet Couns 16:277–282
Butler MG et al (2013) 20q13.2-q13.33 deletion syndrome: a case report. J Pediatr Genet 2:157–161
Blanc P (2008) Trisomy 20q caused by interstitial duplication 20q13.2: clinical report and literature review. Am J Med Genet A 146A:1307–1311
Iglesias A et al (2006) Duplication of distal 20q: clinical, cytogenetic and array CGH. Characterization of a new case. Clin Dysmorphol 15:19–23
Briand-Suleau A et al (2014) SALL4 and NFATC2: two major actors of interstitial 20q13.2 duplication. Eur J Med Genet 57:174–180
Balasubramanian M et al (2015) A novel de novo 20q13.32-q13.33 deletion in a 2-year-old child with poor growth, feeding difficulties and low bone mass. J Hum Genet 60:313–317
Hasstedt SJ et al (2015) A copy number variant on chromosome 20q13.3 implicated in thinness and severe obesity. J Obes 2015:623431. doi:10.1155/2015/623431
Mefford HC, Cook J, Gospe SM Jr (2012) Epilepsy due to 20q13.33 subtelomere deletion masquerading as pyridoxine-dependent epilepsy. Am J Med Genet A 158A:3190–3195
Okumura A et al (2015) Phenotypes of children with 20q13.3 microdeletion affecting KCNQ2 and CHRNA4. Epileptic Disord 17:165–171
Solomon BD et al (2011) De novo deletion of chromosome 20q13.33 in a patient with tracheo-esophageal fistula, cardiac defects and genitourinary defects implicates GTPBP5 as a candidate gene. Birth Defects Res A Clin Mol Teratol 91:862–865
Béna F et al (2007) A de novo 1.1-1.6 Mb subtelomeric deletion of chromosome 20q13.33 in a patient with learning difficulties but without obvious dysmorphic features. Am J Med Genet A 143A:1894–1899
Béri-Deixheimer M et al (2007) Genotype-phenotype correlations to aid in the prognosis of individuals with uncommon 20q13.33 subtelomere deletions: a collaborative study on behalf of the ‘association des Cytogénéticiens de langue Française’. Eur J Hum Genet 15:446–452
Mosca-Boidron AL et al (2013) Additional evidence to support the role of the 20q13.33 region in susceptibility to autism. Am J Med Genet A 161A:1505–1507
McGill AK et al (2010) A tale of two deletions: a report of two novel 20p13 –> pter deletions. Am J Med Genet A 152A:1000–1007
Starr LJ et al (2014) Duplication of 20qter and deletion of 20pter due to paternal pericentric inversion: patient report and review of 20qter duplications. Am J Med Genet A 164A:2020–2024
Grange DK et al (2005) Trisomy 20q13 –> 20qter in a girl with multiple congenital malformations and a recombinant chromosome 20 inherited from a paternal inversion (20)(p13q13.1): clinical report and review of the trisomy 20q phenotype. Am J Med Genet A 137A:308–312
Petit F et al (2015) 21q21 deletion involving NCAM2: report of 3 cases with neurodevelopmental disorders. Eur J Med Genet 58:44–46
Haldeman-Englert CR et al (2010) A de novo 8.8-Mb deletion of 21q21.1-q21.3 in an autistic male with a complex rearrangement involving chromosomes 6, 10, and 21. Am J Med Genet A 152A:196–202
Fukai R et al (2014) A de novo 1.4-Mb deletion at 21q22.11 in a boy with developmental delay. Am J Med Genet A 164A:1021–1028
Eggermann T et al (2010) Identification of a 21q22 duplication in a Silver-Russell syndrome patient further narrows down the Down syndrome critical region. Am J Med Genet A 152A:356–359
Click ES et al (2011) Fanconi anemia-like presentation in an infant with constitutional deletion of 21q including the RUNX1 gene. Am J Med Genet A 155A:1673–1679
Byrd RS et al (2011) Monosomy 21q22.11-q22.13 presenting as a Fanconi anemia phenotype. Am J Med Genet A 155A:120–125
Christensen RD, Wiedmeier SE, Yaish HM (2013) A neonate with congenital amegakaryocytic thrombocytopenia associated with a chromosomal microdeletion at21q22.11 including the gene RUNX1. J Perinatol 33:242–244
Thevenon J et al (2011) De novo 21q22.1q22.2 deletion including RUNX1 mimicking a congenital infection. Am J Med Genet A 155A:126–129
Mallick S et al. (2014) Semilobar holoprosencephaly with 21q22 deletion: an autopsy report. BMJ Case Rep 2014. pii: bcr2014203597. doi:10.1136/bcr-2014-203597
Oegema R et al (2010) Distinctive phenotypic abnormalities associated with submicroscopic 21q22 deletion including DYRK1A. Mol Syndromol 1:113–120
Carrascosa-Romero MC et al (2013) A 2.84 Mb deletion at 21q22.11 in a patient clinically diagnosed with Marden-Walker syndrome. Am J Med Genet A 161A:2281–2290
Chen CP et al (2011) A de novo duplication of chromosome 21q22.11→qter associated with Down syndrome: prenatal diagnosis, molecular cytogenetic characterization and fetal ultrasound findings. Taiwan J Obstet Gynecol 50:492–498
Qi Q et al (2013) A rare de novo duplication of chromosome 21q22.12 → q22.3 with other concomitant deletion and duplication of small fragments in 21q associated with Down syndrome: Prenatal diagnosis, molecular cytogenetic characterization. Mol Cytogenet 6(1):11. doi:10.1186/1755-8166-6-11
Ronan A et al (2007) Familial 4.3 Mb duplication of 21q22 sheds new light on the Down syndrome critical region. J Med Genet 44:448–451
Pelleri MC et al (2016) Systematic reanalysis of partial trisomy 21 cases with or without Down syndrome suggests a small region on21q22.13 as critical to the phenotype. Hum Mol Genet pii:ddw116 [Epub ahead of print]
Valetto A et al (2012) Molecular cytogenetic characterization of an interstitial deletion of chromosome 21 (21q22.13q22.3) in a patient with dysmorphic features, intellectual disability and severe generalized epilepsy. Eur J Med Genet 55:362–366
Burgess T et al (2014) Monosomy 21 seen in live born is unlikely to represent true monosomy 21: a case report and review of the literature. Case Rep Genet 2014:965401. doi:10.1155/2014/965401
Ehling D et al (2004) Mild phenotype in two unrelated patients with a partial deletion of 21q22.2-q22.3 defined by FISH and molecular studies. Am J Med Genet A 131:265–272
Ciocca L et al (2015) Hypoplastic left heart syndrome and 21q22.3 deletion. Am J Med Genet A 167A:579–586
Guion-Almeida ML et al (2012) Frontonasal dysplasia, callosal agenesis, basal encephalocele, and eye defects syndrome with a partial21q22.3 deletion. Am J Med Genet A 158A:1676–1679
Burnside RD (2015) 22q11.21 deletion syndromes: a review of proximal, central, and distal deletions and their associated features. Cytogenet Genome Res 146:89–99
Driscoll DA et al (1992) Deletions and microdeletions of 22q11.2 in velo-cardio-facial syndrome. Am J Med Genet 44:261–268
Goldberg R et al (1993) Velo-cardio-facial syndrome: a review of 120 patients. Am J Med Genet 45:313–319
Bassett AS et al (2005) Clinical features of 78 adults with 22q11 deletion syndrome. Am J Med Genet 138A:307–313
Evers LJ et al (2014) Psychopathology in adults with 22q11 deletion syndrome and moderate and severe intellectual disability. J Intellect Disabil Res 58:915–925
Zaleski C et al (2009) The co-occurrence of early onset Parkinson disease and 22q11.2 deletion syndrome. Am J Med Genet A 149A:525–528
Ben-Shachar S et al (2008) 22q11.2 distal deletion: a recurrent genomic disorder distinct from DiGeorge syndrome and velocardiofacial syndrome. Am J Hum Genet 82:214–221
Mikhail FM et al (2014) The recurrent distal 22q11.2 are often de novo and do not represent a single clinical entity: a proposed categorization system. Genet Med 16:92–100
Tan TY et al (2011) Phenotypic variability of distal 22q11.2 copy number abnormalities. Am J Med Genet 155A:1623–1633
Li D et al (2012) Co-existence of other copy number variations with 22q11.2 deletion or duplication: a modifier for variable phenotypes of the syndrome? Mol Cytogenet 5(1):18. doi:10.1186/1755-8166-5-18
Ensenauer RE et al (2003) Microduplication 22q11.2, an emerging syndrome: clinical, cytogenetic, and molecular analysis of thirteen patients. Am J Hum Genet 73:1027–1040
Wentzel C et al (2008) Clinical variability of the 22q11.2 duplication syndrome. Europ J Med Genet 51:501–510
Pebrel-Richard C et al (2012) An atypical 0.8 Mb inherited duplication of 22q11.2 associated with psychomotor impairment. Eur J Med Genet 55:650–655
Chang J et al (2015) Pachygyria, Epilepsy, hypotonia, and growth retardation in a patient with an atypical 1.33 Mb inherited microduplication at 22q11.23. Gene 569:46–50
Siomou E et al (2012) A 725 kb deletion at 22q13.1 chromosomal region including SOX10 gene in a boy with a neurologic variant of Waardenburg syndrome type 2. Eur J Med Genet 55:641–645
Simenson K et al (2014) A patient with the classic features of Phelan-McDermid syndrome and a high immunoglobulin E level caused by a cryptic interstitial 0.72-Mb deletion in the 22q13.2 region. Am J Med Genet A 164A:806–809
Disciglio V et al (2014) Interstitial 22q13 deletions not involving SHANK3 gene: a new contiguous gene syndrome. Am J Med Genet A 164A:1666–1676
Phelan MC et al (2001) 22q13 deletion syndrome. Am J Med Genet 101:91–99
Sarasua SM et al (2014) 22q13.2q13.32 genomic regions associated with severity of speech delay, developmental delay, and physical features in Phelan-McDermid syndrome. Genet Med 16:318–328
Aldinger KA et al (2013) Cerebellar and posterior fossa malformations in patients with autism-associated chromosome 22q13 terminal deletion. Am J Med Genet A 161A:131–136
Sarasua SM et al (2011) Association between deletion size and important phenotypes expands the genomic region of interest in Phelan-McDermid syndrome (22q13 deletion syndrome). J Med Genet 48:761–766
Bertorelli R et al (2007) The homozygous deletion of the 3-prime enhancer of the SHOX gene causes Langer mesomelic dysplasia. (Letter). Clin Genet 72:490–491
Sabherwal N et al (2007) Long-range conserved non-coding SHOX sequences regulate expression in developing chicken limb and are associated with short stature phenotypes in human patients. Hum Molec Genet 16:210–222
Lintas C et al (2016) Xp22.33p22.12 duplication in a patient with intellectual disability and dysmorphic facial features. Mol Syndromol 6(5):236–241. doi:10.1159/000443232
Zhang J et al (2015) A rare novel copy number variation of Xp22.33-p11.22 duplication is associated with congenital heart defects. Chin Med J (Engl) 128:2829–2830
Salaria M et al (2012) Phenotype in novel Xp duplication. Am J Med Genet A 158A:2342–2346
Curry CJR et al (1984) Inherited chondrodysplasia punctata due to a deletion of the terminal short arm of an X chromosome. New Eng J Med 311:1010–1015
Chocholska S et al (2006) Molecular cytogenetic analysis of a familial interstitial deletion Xp22.2-22.3 with a highly variable phenotype in female carriers. Am J Med Genet A 140:604–610
Hosomi N et al (2007) Deletion of distal promoter of VCXA in a patient with X-linked ichthyosis associated with borderline mental retardation. J Dermatol Sci 45:31–36
Macarov M et al (2007) Deletions of VCX-A and NLGN4: a variable phenotype including normal intellect. J Intellect Disabil Res 51:329–333
Mochel F et al (2008) Normal intelligence and social interactions in a male patient despite the deletion of NLGN4X and the VCX genes. Eur J Med Genet 51:68–73
Esplin ED et al (2014) Nine patients with Xp22.31 microduplication, cognitive deficits, epilepsy, and talipes defects. Am J Med Genet A 164A:2097–2103
Faletra F et al (2012) Does the 1.5 Mb microduplication in chromosome band Xp22.31 have a pathogenetic role? New contribution and a review of the literature. Am J Med Genet A 158A:461–464
Li F et al (2010) Interstitial microduplication of Xp22.31: causative of intellectual disability or benign copy number variant? Eur J Med Genet 53:93–99
Sowińska-Seidler A et al (2015) Hyperosmia, ectrodactyly, mild intellectual disability, and other defects in a male patient with an X-linked partial microduplication and overexpression of the KAL1 gene. J Appl Genet 56(2):177–184. doi:10.1007/s13353-014-0252-7
Meindl A et al (1993) Analysis of a terminal Xp22.3 deletion in a patient with six monogenic disorders: implications for the mapping of X linked ocular albinism. J Med Genet 30:838–842
Van Esch H et al (2007) Encephalopathy and bilateral cataract in a boy with an interstitial deletion of Xp22 comprising the CDKL5 and NHS genes. Am J Med Genet 143A:364–369
Liao H-M et al (2011) Identification of a microdeletion at Xp22.13 in a Taiwanese family presenting with Nance-Horan syndrome. J Hum Genet 56:8–11
Sismani C et al (2011) 9 Mb familial duplication in chromosome band Xp22.2-22.13 associated with mental retardation, hypotonia and developmental delay, scoliosis, cardiovascular problems and mild dysmorphic facial features. Eur J Med Genet 54:e510–e515. doi:10.1016/j.ejmg.2011.05.006
Popovici C et al (2014) Whole ARX gene duplication is compatible with normal intellectual development. Am J Med Genet A 164A:2324–2327
Billuart P et al (1996) Identification by STS PCR screening of a microdeletion in Xp21.3-22.1 associated with non-specific mental retardation. Hum Molec Genet 5:977–979
Tabolacci E et al (2006) A truncating mutation in the IL1RAPL1 gene is responsible for X-linked mental retardation in the MRX21 family. Am J Med Genet 140A:482–487
Matsumoto A et al (2013) An Xp22.12 microduplication including RPS6KA3 identified in a family with variably affected intellectual and behavioral disabilities. J Hum Genet 58:755–757
Tejada MI et al (2011) A child with mild X-linked intellectual disability and a microduplication at Xp22.12 including RPS6KA3. Pediatrics 128:e1029–e1033
Francke U et al (1987) Congenital adrenal hypoplasia, myopathy, and glycerol kinase deficiency: molecular genetic evidence for deletions. Am J Hum Genet 40:212–227
Lederer D et al (2012) Deletion of KDM6A, a histone demethylase interacting with MLL2, in three patients with Kabuki syndrome. Am J Hum Genet 90:119–124
Collins FA et al (1992) Clinical, biochemical, and neuropsychiatric evaluation of a patient with a contiguous gene syndrome due to a microdeletion Xp11.3 including the Norrie disease locus and monoamine oxidase (MAOA and MAOB) genes. Am J Med Genet 42:127–134
Zhang L et al (2006) A microdeletion in Xp11.3 accounts for co-segregation of retinitis pigmentosa and mental retardation in a large kindred. Am J Med Genet 140A:349–357
Lugtenberg D et al (2006) ZNF674: a new Kruppel-associated box-containing zinc-finger gene involved in nonsyndromic X-linked mental retardation. Am J Hum Genet 78:265–278
Grzeschik K-H et al (2007) Deficiency of PORCN, a regulator of Wnt signaling, is associated with focal dermal hypoplasia. Nature Genet 39:833–835
Wang X et al (2007) Mutations in X-linked PORCN, a putative regulator of Wnt signaling, cause focal dermal hypoplasia. Nature Genet 39:836–838
Qiao Y et al (2008) Autism-associated familial microdeletion of Xp11.22. Clin Genet 74:134–144
Froyen G et al (2012) Copy-number gains of HUWE1 due to replication- and recombination-based rearrangements. Am J Hum Genet 91:252–264
Prontera P et al (2012) Xq12-q13.3 duplication: evidence of a recurrent syndrome. Ann Neurol 72:821–822
Kaya N et al (2012) A novel X-linked disorder with developmental delay and autistic features 71:498–508
Nur MM et al (2016) Chromosome Xq13.2 Microduplication involving an X-Inactivation gene in a girl with short stature, Madelung deformity, and von Willebrand Disease. J Pediatr Adolesc Gynecol 29:e39–e42
Wentz E et al (2014) A case report of two male siblings with autism and duplication of Xq13-q21, a region including three genes predisposing for autism. Eur Child Adolesc Psychiatry 23:329–336
Huber I et al (1994) X-linked mixed deafness (DFN3): cloning and characterization of the critical region allows the identification of novel microdeletions. Hum Molec Genet 3:1151–1154
Giordano M et al (2015) A 5.8 Mb interstitial deletion on chromosome Xq21.1 in a boy with intellectual disability, cleft palate, hearing impairment and combined growth hormone deficiency. BMC Med Genet 16:74. doi:10.1186/s12881-015-0220-z
Gabbett MT et al (2008) Prader-Willi syndrome phenocopy due to duplication of Xq21.1-q21.31, with array CGH of the critical region. Clin Genet 73:353–359
Cheroki C et al (2008) Genomic imbalances associated with mullerian aplasia. J Med Genet 45:228–232
Speevak MD, Farrell SA (2011) Non-syndromic language delay in a child with disruption in the Protocadherin11X/Y gene pair. Am J Med Genet B Neuropsychiatr Genet 156B:484–489
Veerappa AM et al (2013) Genome-wide copy number scan identifies disruption of PCDH11X in developmental dyslexia. Am J Med Genet B Neuropsychiatr Genet 162B:889–897
Castro-Gago M et al (2013) A Xq21.31 duplication without features of Prader-Willi syndrome. Endocrine 43(1):238. doi:10.1007/s12020-012-9738-4
Basit S et al (2016) Xq21.31-q21.32 duplication underlies intellectual disability in a large family with five affected males. Am J Med Genet A 170:87–93
Vincent AK et al (2012) Identification of genomic deletions spanning the PCDH19 gene in two unrelated girls with intellectual disability and epilepsy. Clin Genet 82:540–545
Leroy C et al (2016) Xq25 duplication: the crucial role of the STAG2 gene in this novel human cohesinopathy. Clin Genet 89:68–73
Di Benedetto D et al (2014) Definition of minimal duplicated region encompassing the XIAP and STAG2 genes in the Xq25 microduplication syndrome. Am J Med Genet A 164A:1923–1930
Yingjun X et al (2014) Microduplication of chromosome Xq25 encompassing STAG2 gene in a boy with intellectual disability. Eur J Med Genet 58:116–121
Philippe A et al (2013) Xq25 duplications encompassing GRIA3 and STAG2 genes in two families convey recognizable X-linked intellectual disability with distinctive facial appearance. Am J Med Genet A 161A:1370–1375
Schroer RJ et al (2012) Duplication of OCRL and adjacent genes associated with autism but not Lowe syndrome. Am J Med Genet A 158A:2602–2605
Møller RS et al (2014) X-linked congenital ptosis and associated intellectual disability, short stature, microcephaly, cleft palate, digital and genital abnormalities define novel Xq25q26 duplication syndrome. Hum Genet 133:625–638
Ricks CB et al (2010) Delineation of a 1.65 Mb critical region for hemihyperplasia and digital defects on Xq25. Am J Med Genet A 152A:453–458
Solomon NM et al (2002) Increased gene dosage at Xq26-q27 is associated with X-linked hypopituitarism. Genomics 79:553–559
Trivellin G et al (2014) Gigantism and acromegaly due to Xq26 microduplications and GPR101 mutation. New Eng J Med 371:2363–2374
Abu-Amero KK et al (2014) Xq26.3 microdeletion in a male with Wildervanck syndrome. Ophthalmic Genet 35:18–24
Marshall LS et al (2013) Deletion Xq27.3q28 in female patient with global developmental delays and skewed X-inactivation. BMC Med Genet 14:49. doi:10.1186/1471-2350-14-49
Probst FJ et al (2007) Chromosomal microarray analysis (CMA) detects a large X chromosome deletion including FMR1, FMR2, and IDS in a female patient with mental retardation. Am J Med Genet A 143A:1358–1365
Brusius-Facchin AC et al (2012) Severe phenotype in MPS II patients associated with a large deletion including contiguous genes. Am J Med Genet A 158A:1055–1059
Sahoo T et al (2011) Microdeletion of Xq28 involving the AFF2 (FMR2) gene in two unrelated males with developmental delay. Am J Med Genet A 155A:3110–3115
Bartsch O et al (1999) The novel contiguous gene syndrome of myotubular myopathy (MTM1), male hypogenitalism and deletion in Xq28: report of the first familial case. Cytogenet Cell Genet 85:310–314
Osaka H et al (2012) Contiguous deletion of SLC6A8 and BAP31 in a patient with severe dystonia and sensorineural deafness. Mol Genet Metab 106:43–47
Calhoun AR, Raymond GV (2014) Distal Xq28 microdeletions: clarification of the spectrum of contiguous gene deletions involving ABCD1, BCAP31, and SLC6A8 with a new case and review of the literature. Am J Med Genet A 164A:2613–2617
Iwasa M et al (2013) Contiguous ABCD1 DXS1357E deletion syndrome: report of an autopsy case. Neuropathology 33:292–298
Tegay DH et al (2007) Contiguous gene deletion involving L1CAM and AVPR2 causes X-linked hydrocephalus with nephrogenic diabetes insipidus. Am J Med Genet A 143A:594–598
Knops NB et al (2008) Nephrogenic diabetes insipidus in a patient with L1 syndrome: a new report of a contiguous gene deletion syndrome including L1CAM and AVPR2. Am J Med Genet A 146A:1853–1858
Cho SY et al (2016) Novel large deletion in AVPR2 gene causing copy number variation in a patient with X-linked nephrogenic diabetes insipidus. Clin Chim Acta 455:84–86
Broides A et al (2006) Severe combined immunodeficiency associated with nephrogenic diabetes insipidus and a deletion in the Xq28region. Clin Immunol 120:147–155
Iourov IY et al (2013) Xq28 (MECP2) microdeletions are common in mutation-negative females with Rett syndrome and cause mild subtypes of the disease. Mol Cytogenet 6(1):53. doi:10.1186/1755-8166-6-53
Yatsenko SA et al (2016) High-resolution microarray analysis unravels complex Xq28 aberrations in patients and carriers affected by X-linked blue cone monochromacy. Clin Genet 89:82–87
Singh HR et al (2009) A novel Alu-mediated Xq28 microdeletion ablates TAZ and partially deletes DNL1L in a patient with Barth syndrome. Am J Med Genet A 149A:1082–1085
Fink JM et al (1997) Identification of a duplication of Xq28 associated with bilateral periventricular nodular heterotopia. Am J Hum Genet 61:379–387
Clayton-Smith J et al (2009) Xq28 duplication presenting with intestinal and bladder dysfunction and a distinctive facial appearance. Europ J Hum Genet 17:434–443
Yamamoto T et al (2014) Clinical impacts of genomic copy number gains at Xq28. Hum Genome Var 1:14001. doi:10.1038/hgv.2014.1
El Chehadeh S et al (2015) Large national series of patients with Xq28 duplication involving MECP2: Delineation of brain MRI abnormalities in 30 affected patients. Am J Med Genet A 170:116–129
Scott Schwoerer J et al (2014) MECP2 duplication: possible cause of severe phenotype in females. Am J Med Genet A 164A:1029–1034
Bijlsma EK et al (2011) De novo MECP2 duplication in two females with random X-inactivation and moderate mental retardation. Eur J Hum Genet 19:507–512
El-Hattab AW et al (2015) Clinical characterization of int22h1/int22h2-mediated Xq28 duplication/deletion: new cases and literature review. BMC Med Genet 16:12. doi:10.1186/s12881-015-0157-2
van Asbeck E et al (2014) Duplication at Xq28 involving IKBKG is associated with progressive macrocephaly, recurrent infections, ectodermal dysplasia, benign tumors, and neuropathy. Clin Dysmorphol 23:77–82
Ma K et al (1992) Towards the molecular localisation of the AZF locus: mapping of microdeletions in azoospermic men within 14 subintervals of interval 6 of the human Y chromosome. Hum Molec Genet 1:29–33
Vogt PH et al (1996) Human Y chromosome azoospermia factors (AZF) mapped to different subregions in Yq11. Hum Molec Genet 5:933–943
Wiland E et al (2015) FISH and array CGH characterization of de novo derivative Y chromosome (Yq duplication and partial Yp deletion) in an azoospermic male. Reprod Biomed Online 31:217–224. doi:10.1016/j.rbmo.2015.04.014
Shi YC et al (2011) A rare Y chromosome constitutional rearrangement: a partial AZFb deletion and duplication within chromosome Yp in an infertile man with severe oligoasthenoteratozoospermia. Int J Androl 34:461–469. doi:10.1111/j.1365-2605.2010.01098.x
Pryor JL et al (1997) Microdeletions in the Y chromosome of infertile men. New Eng J Med 336:534–539
Zhang et al (2007) Partial deletions are associated with an increased risk of complete deletion in AZFc: a new insight into the role of partial AZFc deletions in male infertility. J Med Genet 44:437–444
Foresta C, Moro E, Ferlin A (2001) Y chromosome microdeletions and alterations of spermatogenesis. Endocr Rev 22:226–239
Lin Y-W et al (2007) Partial duplication at AZFc on the Y chromosome is a risk factor for impaired spermatogenesis in Han Chinese in Taiwan. Hum Mutat 28:486–494
Engelen JJ et al (2003) Intrachromosomal insertion translocation resulting in duplication of chromosome band Yq11.2 in two fertile brothers. Am J Med Genet A 118A:287–289
Ferlin A et al (2003) The human Y chromosome’s azoospermia factor b (AZFb) region: sequence, structure, and deletion analysis in infertile men. J Med Genet 40:18–24
Luddi A et al (2009) Spermatogenesis in a man with complete deletion of USP9Y. New Eng J Med 360:881–885
Duell T et al (1998) Interstitial and terminal deletion of chromosome Y in a male individual with cryptozoospermia. Mol Hum Reprod 4:325–331
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2017 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Wyandt, H.E., Wilson, G.N., Tonk, V.S. (2017). A CNV Catalogue. In: Human Chromosome Variation: Heteromorphism, Polymorphism and Pathogenesis. Springer, Singapore. https://doi.org/10.1007/978-981-10-3035-2_10
Download citation
DOI: https://doi.org/10.1007/978-981-10-3035-2_10
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-10-3034-5
Online ISBN: 978-981-10-3035-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)